Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Eleftherios Diamandis

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Disorders

Procedures

Concepts & Ideas

Physiology

Neoplastic Gene Expression Regulation

Genes & Molecular Sequences

Amino Acid Sequence

Anatomy

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Oikonomopoulou Katerina; Soosaipillai Antoninus; Diamandis Eleftherios P
Evaluation of prostate-specific antigen as a novel biomarker of Hsp90 inhibition.
Gunawardana C Geeth; Kuk Cynthia; Smith Chris R; Batruch Ihor; Soosaipillai Antoninus; Diamandis Eleftherios P
Comprehensive analysis of conditioned media from ovarian cancer cell lines identifies novel candidate markers of epithelial ovarian cancer.
Christensen Eva; Pintilie Melania; Evans Kenneth R; Lenarduzzi Michelle; Ménard Cynthia; Catton Charles N; Diamandis Eleftherios P; Bristow Robert G
Longitudinal cytokine expression during IMRT for prostate cancer and acute treatment toxicity.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Eleftherios Diamandis (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Oikonomopoulou Katerina; Soosaipillai Antoninus; Diamandis Eleftherios P
Evaluation of prostate-specific antigen as a novel biomarker of Hsp90 inhibition.
Clinical biochemistry 2009;42(16-17):1705-12.
2009: Gunawardana C Geeth; Kuk Cynthia; Smith Chris R; Batruch Ihor; Soosaipillai Antoninus; Diamandis Eleftherios P
Comprehensive analysis of conditioned media from ovarian cancer cell lines identifies novel candidate markers of epithelial ovarian cancer.
Journal of proteome research 2009;8(10):4705-13.
2009: Christensen Eva; Pintilie Melania; Evans Kenneth R; Lenarduzzi Michelle; Ménard Cynthia; Catton Charles N; Diamandis Eleftherios P; Bristow Robert G
Longitudinal cytokine expression during IMRT for prostate cancer and acute treatment toxicity.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(17):5576-83.
2009: Sardana Girish; Diamandis Eleftherios P
The kallikrein family of proteins as urinary biomarkers for the detection of prostate cancer.
Clinical biochemistry 2009;42(13-14):1483-6.
2009: Emami Nashmil; Scorilas Andreas; Soosaipillai Antoninus; Earle Tammy; Mullen Brendan; Diamandis Eleftherios P
Association between kallikrein-related peptidases (KLKs) and macroscopic indicators of semen analysis: their relation to sperm motility.
Biological chemistry 2009;390(9):921-9.
2009: Strojnik Tadej; Kavalar Rajko; Zajc Irena; Diamandis Eleftherios P; Oikonomopoulou Katerina; Lah Tamara T
Prognostic impact of CD68 and kallikrein 6 in human glioma.
Anticancer research 2009;29(8):3269-79.
2009: Pavlou Maria; Diamandis Eleftherios P
The search for new prostate cancer biomarkers continues.
Clinical chemistry 2009;55(7):1277-9.
2009: Diamandis Eleftherios P; Hanash Samir; Lopez Mary; Carr Steven; Petricoin Emanuel F
Protein quantification by mass spectrometry: is it ready for prime time?
Clinical chemistry 2009;55(7):1427-30.
2009: Kulasingam Vathany; Zheng Yingye; Soosaipillai Antoninus; Leon Antonette E; Gion Massimo; Diamandis Eleftherios P
Activated leukocyte cell adhesion molecule: a novel biomarker for breast cancer.
International journal of cancer. Journal international du cancer 2009;125(1):9-14.
2009: Talieri M; Li L; Zheng Y; Alexopoulou D K; Soosaipillai A; Scorilas A; Xynopoulos D; Diamandis E P
The use of kallikrein-related peptidases as adjuvant prognostic markers in colorectal cancer.
British journal of cancer 2009;100(10):1659-65.
2009: Talieri Maroulio; Mathioudaki Konstantina; Prezas Panagiotis; Alexopoulou Dimitra K; Diamandis Eleftherios P; Xynopoulos Dimitris; Ardavanis Alexandros; Arnogiannaki Niki; Scorilas Andreas
Clinical significance of kallikrein-related peptidase 7 (KLK7) in colorectal cancer.
Thrombosis and haemostasis 2009;101(4):741-7.
2009: Chen Yu; Yazdanpanah Mehrdad; Hoffman Barry R; Diamandis Eleftherios P; Wong Pui-Yuen
Rapid determination of serum testosterone by liquid chromatography-isotope dilution tandem mass spectrometry and a split sample comparison with three automated immunoassays.
Clinical biochemistry 2009;42(6):484-90.
2009: Kuzmanov Uros; Jiang Nianxin; Smith Christopher R; Soosaipillai Antoninus; Diamandis Eleftherios P
Differential N-glycosylation of kallikrein 6 derived from ovarian cancer cells or the central nervous system.
Molecular & cellular proteomics : MCP 2009;8(4):791-8.
2009: Kuk Cynthia; Kulasingam Vathany; Gunawardana C Geeth; Smith Chris R; Batruch Ihor; Diamandis Eleftherios P
Mining the ovarian cancer ascites proteome for potential ovarian cancer biomarkers.
Molecular & cellular proteomics : MCP 2009;8(4):661-9.
2009: Kountourakis Panteleimon; Psyrri Amanda; Scorilas Andreas; Markakis Sonia; Kowalski Diane; Camp Robert L; Diamandis Eleftherios P; Dimopoulos Meletios A
Expression and prognostic significance of kallikrein-related peptidase 8 protein levels in advanced ovarian cancer by using automated quantitative analysis.
Thrombosis and haemostasis 2009;101(3):541-6.
2009: Gunawardana C Geeth; Memari Nader; Diamandis Eleftherios P
Identifying novel autoantibody signatures in ovarian cancer using high-density protein microarrays.
Clinical biochemistry 2009;42(4-5):426-9.
2009: Cherney David Z I; Konvalinka Ana; Zinman Bernard; Diamandis Eleftherios P; Soosaipillai Anton; Reich Heather; Lorraine Joanne; Lai Vesta; Scholey James W; Miller Judith A
Effect of protein kinase Cbeta inhibition on renal hemodynamic function and urinary biomarkers in humans with type 1 diabetes: a pilot study.
Diabetes care 2009;32(1):91-3.
2009: Diamandis Eleftherios P
Journal Impact Factor: it will go away soon.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2009;47(11):1317-8.
2009: Yousef George M; Diamandis Eleftherios P
The human kallikrein gene family: new biomarkers for ovarian cancer.
Cancer treatment and research 2009;149():165-87.
2008: Sturgeon Catharine M; Duffy Michael J; Stenman Ulf-Håkan; Lilja Hans; Brünner Nils; Chan Daniel W; Babaian Richard; Bast Robert C; Dowell Barry; Esteva Francisco J; Haglund Caj; Harbeck Nadia; Hayes Daniel F; Holten-Andersen Mads; Klee George G; Lamerz Rolf; Looijenga Leendert H; Molina Rafael; Nielsen Hans Jørgen; Rittenhouse Harry; Semjonow Axel; Shih Ie-Ming; Sibley Paul; Sölétormos György; Stephan Carsten; Sokoll Lori; Hoffman Barry R; Diamandis Eleftherios P;
National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers.
Clinical chemistry 2008;54(12):e11-79.
2008: Sardana Girish; Dowell Barry; Diamandis Eleftherios P
Emerging biomarkers for the diagnosis and prognosis of prostate cancer.
Clinical chemistry 2008;54(12):1951-60.
2008: Shaw Julie L V; Diamandis Eleftherios P
Regulation of human tissue kallikrein-related peptidase expression by steroid hormones in 32 cell lines.
Biological chemistry 2008;389(11):1409-19.
2008: Kountourakis Panteleimon; Psyrri Amanda; Scorilas Andreas; Camp Robert; Markakis Sonia; Kowalski Diane; Diamandis Eleftherios P; Dimopoulos Meletios A
Prognostic value of kallikrein-related peptidase 6 protein expression levels in advanced ovarian cancer evaluated by automated quantitative analysis (AQUA).
Cancer science 2008;99(11):2224-9.
2008: Prassas Ioannis; Diamandis Eleftherios P
Novel therapeutic applications of cardiac glycosides.
Nature reviews. Drug discovery 2008;7(11):926-35.
2008: Diamandis Eleftherios P; Hoffman Barry R; Sturgeon Catharine M
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for the Use of Tumor Markers.
Clinical chemistry 2008;54(11):1935-9.
2008: Kulasingam Vathany; Diamandis Eleftherios P
Tissue culture-based breast cancer biomarker discovery platform.
International journal of cancer. Journal international du cancer 2008;123(9):2007-12.
2008: Bayani Jane; Paliouras Miltiadis; Planque Chris; Shan Shannon J C; Graham Cassandra; Squire Jeremy A; Diamandis Eleftherios P
Impact of cytogenetic and genomic aberrations of the kallikrein locus in ovarian cancer.
Molecular oncology 2008;2(3):250-60.
2008: Oikonomopoulou K; Li L; Zheng Y; Simon I; Wolfert R L; Valik D; Nekulova M; Simickova M; Frgala T; Diamandis E P
Prediction of ovarian cancer prognosis and response to chemotherapy by a serum-based multiparametric biomarker panel.
British journal of cancer 2008;99(7):1103-13.
2008: Kulasingam Vathany; Diamandis Eleftherios P
Strategies for discovering novel cancer biomarkers through utilization of emerging technologies.
Nature clinical practice. Oncology 2008;5(10):588-99.
2008: Emami Nashmil; Diamandis Eleftherios P
Utility of kallikrein-related peptidases (KLKs) as cancer biomarkers.
Clinical chemistry 2008;54(10):1600-7.
2008: Prassas Ioannis; Paliouras Miltiadis; Datti Alessandro; Diamandis Eleftherios P
High-throughput screening identifies cardiac glycosides as potent inhibitors of human tissue kallikrein expression: implications for cancer therapies.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(18):5778-84.
2008: Sharma Navneet; Oikonomopoulou Katerina; Ito Kenichi; Renaux Bernard; Diamandis Eleftherios P; Hollenberg Morley D; Rancourt Derrick E
Substrate specificity determination of mouse implantation serine proteinase and human kallikrein-related peptidase 6 by phage display.
Biological chemistry 2008;389(8):1097-105.
2008: Hansen Kristina K; Oikonomopoulou Katerina; Baruch Amos; Ramachandran Rithwik; Beck Paul; Diamandis Eleftherios P; Hollenberg Morley D
Proteinases as hormones: targets and mechanisms for proteolytic signaling.
Biological chemistry 2008;389(8):971-82.
2008: Sturgeon Catharine M; Hoffman Barry R; Chan Daniel W; Ch'ng Soo-Ling; Hammond Elizabeth; Hayes Daniel F; Liotta Lance A; Petricoin Emmanuel F; Schmitt Manfred; Semmes O John; Söletormos Györg; van der Merwe Elena; Diamandis Eleftherios P;
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in clinical practice: quality requirements.
Clinical chemistry 2008;54(8):e1-e10.
2008: Sardana Girish; Jung Klaus; Stephan Carsten; Diamandis Eleftherios P
Proteomic analysis of conditioned media from the PC3, LNCaP, and 22Rv1 prostate cancer cell lines: discovery and validation of candidate prostate cancer biomarkers.
Journal of proteome research 2008;7(8):3329-38.
2008: Emami Nashmil; Deperthes David; Malm Johan; Diamandis Eleftherios P
Major role of human KLK14 in seminal clot liquefaction.
The Journal of biological chemistry 2008;283(28):19561-9.
2008: Psyrri A; Kountourakis P; Scorilas A; Markakis S; Camp R; Kowalski D; Diamandis E P; Dimopoulos M A
Human tissue kallikrein 7, a novel biomarker for advanced ovarian carcinoma using a novel in situ quantitative method of protein expression.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(7):1271-7.
2008: Paliouras Miltiadis; Diamandis Eleftherios P
An AKT activity threshold regulates androgen-dependent and androgen-independent PSA expression in prostate cancer cell lines.
Biological chemistry 2008;389(6):773-80.
2008: Planque Chris; Bléchet Claire; Ayadi-Kaddour Aida; Heuzé-Vourc'h Nathalie; Dumont Pascal; Guyétant Serge; Diamandis Eleftherios P; El Mezni Faouzi; Courty Yves
Quantitative RT-PCR analysis and immunohistochemical localization of the kallikrein-related peptidases 13 and 14 in lung.
Biological chemistry 2008;389(6):781-6.
2008: Scarisbrick Isobel A; Linbo Rachel; Vandell Alexander G; Keegan Mark; Blaber Sachiko I; Blaber Michael; Sneve Diane; Lucchinetti Claudia F; Rodriguez Moses; Diamandis Eleftherios P
Kallikreins are associated with secondary progressive multiple sclerosis and promote neurodegeneration.
Biological chemistry 2008;389(6):739-45.
2008: Eissa Azza; Diamandis Eleftherios P
Human tissue kallikreins as promiscuous modulators of homeostatic skin barrier functions.
Biological chemistry 2008;389(6):669-80.
2008: Shaw Julie L V; Diamandis Eleftherios P
A potential role for tissue kallikrein-related peptidases in human cervico-vaginal physiology.
Biological chemistry 2008;389(6):681-8.
2008: Hollenberg Morley D; Oikonomopoulou Katerina; Hansen Kristina K; Saifeddine Mahmoud; Ramachandran Rithwik; Diamandis Eleftherios P
Kallikreins and proteinase-mediated signaling: proteinase-activated receptors (PARs) and the pathophysiology of inflammatory diseases and cancer.
Biological chemistry 2008;389(6):643-51.
2008: Oikonomopoulou Katerina; Hansen Kristina K; Baruch Amos; Hollenberg Morley D; Diamandis Eleftherios P
Immunofluorometric activity-based probe analysis of active KLK6 in biological fluids.
Biological chemistry 2008;389(6):747-56.
2008: Chow Tsz-fung F; Crow Megan; Earle Tammy; El-Said Hala; Diamandis Eleftherios P; Yousef George M
Kallikreins as microRNA targets: an in silico and experimental-based analysis.
Biological chemistry 2008;389(6):731-8.
2008: Komatsu Nahoko; Saijoh Kiyofumi; Jayakumar Arumugam; Clayman Gary L; Tohyama Mikiko; Suga Yasushi; Mizuno Yuki; Tsukamoto Katsuhiko; Taniuchi Katsushige; Takehara Kazuhiko; Diamandis Eleftherios P
Correlation between SPINK5 gene mutations and clinical manifestations in Netherton syndrome patients.
The Journal of investigative dermatology 2008;128(5):1148-59.
2008: Paliouras Miltiadis; Diamandis Eleftherios P
Androgens act synergistically to enhance estrogen-induced upregulation of human tissue kallikreins 10, 11, and 14 in breast cancer cells via a membrane bound androgen receptor.
Molecular oncology 2008;1(4):413-24.
2008: Planque Chris; Li Lin; Zheng Yingye; Soosaipillai Antoninus; Reckamp Karen; Chia David; Diamandis Eleftherios P; Goodglick Lee
A multiparametric serum kallikrein panel for diagnosis of non-small cell lung carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(5):1355-62.
2008: Heshmat Samy M; Mullen J Brendan; Jarvi Keith A; Soosaipillai Antoninus; Diamandis Eleftherios P; Hamilton Robert J; Lo Kirk C
Seminal plasma lipocalin-type prostaglandin D synthase: a potential new marker for the diagnosis of obstructive azoospermia.
The Journal of urology 2008;179(3):1077-80.
2008: Kulasingam Vathany; Smith Christopher R; Batruch Ihor; Buckler Alan; Jeffery Douglas A; Diamandis Eleftherios P
"Product ion monitoring" assay for prostate-specific antigen in serum using a linear ion-trap.
Journal of proteome research 2008;7(2):640-7.
2008: Emami Nashmil; Diamandis Eleftherios P
Human kallikrein-related peptidase 14 (KLK14) is a new activator component of the KLK proteolytic cascade. Possible function in seminal plasma and skin.
The Journal of biological chemistry 2008;283(6):3031-41.
2008: Maki Jennifer; Robinson Kerry; Reguly Brian; Alexander Jude; Wittock Roy; Aguirre Andrea; Diamandis Eleftherios P; Escott Nicholas; Skehan Anthony; Prowse Owen; Thayer Robert E; Froberg M Kent; Wilson Michael J; Maragh Samantha; Jakupciak John P; Wagner Paul D; Srivastava Sudhir; Dakubo Gabriel D; Parr Ryan L
Mitochondrial genome deletion aids in the identification of false- and true-negative prostate needle core biopsy specimens.
American journal of clinical pathology 2008;129(1):57-66.
2008: Paliouras Miltiadis; Diamandis Eleftherios P
Intracellular signaling pathways regulate hormone-dependent kallikrein gene expression.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2008;29(2):63-75.
2008: Rabien Anja; Fritzsche Florian; Jung Monika; Diamandis Eleftherios P; Loening Stefan A; Dietel Manfred; Jung Klaus; Stephan Carsten; Kristiansen Glen
High expression of KLK14 in prostatic adenocarcinoma is associated with elevated risk of prostate-specific antigen relapse.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2008;29(1):1-8.
2007: Goard Carolyn A; Bromberg Irvin L; Elliott Marc B; Diamandis Eleftherios P
A consolidated catalogue and graphical annotation of dbSNP polymorphisms in the human tissue kallikrein (KLK) locus.
Molecular oncology 2007;1(3):303-12.
2007: Emami Nashmil; Diamandis Eleftherios P
New insights into the functional mechanisms and clinical applications of the kallikrein-related peptidase family.
Molecular oncology 2007;1(3):269-87.
2007: Yousef George M; Denic Nebojsa; Wadhwa Jasbir; Chandracanth Soornahalli A; Smith Thomas; Elms Ford; Diamandis Eleftherios P
Intravagal ectopic parathyroid presenting as vocal cord paralysis: case report and review of the literature.
The Journal of otolaryngology 2007;36(6):E93-5.
2007: Zheng Yingye; Katsaros Dionyssios; Shan Shannon J C; de la Longrais Irene Rigault; Porpiglia Mauro; Scorilas Andreas; Kim Nam W; Wolfert Robert L; Simon Iris; Li Lin; Feng Ziding; Diamandis Eleftherios P
A multiparametric panel for ovarian cancer diagnosis, prognosis, and response to chemotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(23):6984-92.
2007: Diamandis Eleftherios P
POINT: EPCA-2: a promising new serum biomarker for prostatic carcinoma?
Clinical biochemistry 2007;40(18):1437-9.
2007: Borgoño Carla A; Gavigan Julie-Ann; Alves Juliano; Bowles Ben; Harris Jennifer L; Sotiropoulou Georgia; Diamandis Eleftherios P
Defining the extended substrate specificity of kallikrein 1-related peptidases.
Biological chemistry 2007;388(11):1215-25.
2007: Kulasingam Vathany; Diamandis Eleftherios P
Proteomics analysis of conditioned media from three breast cancer cell lines: a mine for biomarkers and therapeutic targets.
Molecular & cellular proteomics : MCP 2007;6(11):1997-2011.
2007: Kulasingam Vathany; Diamandis Eleftherios P
Glucocorticoid receptor-mediated expression of kallikrein 10 in human breast cancer cell lines.
Biological chemistry 2007;388(10):1113-9.
2007: Stephan Carsten; Jung Klaus; Lein Michael; Diamandis Eleftherios P
PSA and other tissue kallikreins for prostate cancer detection.
European journal of cancer (Oxford, England : 1990) 2007;43(13):1918-26.
2007: Memari Nader; Diamandis Eleftherios P; Earle Tammy; Campbell Alison; Van Dekken Herman; Van der Kwast Theodore H
Human kallikrein-related peptidase 12: antibody generation and immunohistochemical localization in prostatic tissues.
The Prostate 2007;67(13):1465-74.
2007: McIntosh Martin W; Liu Yan; Drescher Charles; Urban Nicole; Diamandis Eleftherios P
Validation and characterization of human kallikrein 11 as a serum marker for diagnosis of ovarian carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(15 Pt 1):4422-8.
2007: Shaw Julie L V; Diamandis Eleftherios P
Distribution of 15 human kallikreins in tissues and biological fluids.
Clinical chemistry 2007;53(8):1423-32.
2007: Simon Iris; Katsaros Dionyssios; Rigault de la Longrais Irene; Massobrio Marco; Scorilas Andreas; Kim Nam W; Sarno Mark J; Wolfert Robert L; Diamandis Eleftherios P
B7-H4 is over-expressed in early-stage ovarian cancer and is independent of CA125 expression.
Gynecologic oncology 2007;106(2):334-41.
2007: Cho Chan-Kyung J; Shan Shannon J; Winsor Elizabeth J; Diamandis Eleftherios P
Proteomics analysis of human amniotic fluid.
Molecular & cellular proteomics : MCP 2007;6(8):1406-15.
2007: Shaw Julie L V; Smith Christopher R; Diamandis Eleftherios P
Proteomic analysis of human cervico-vaginal fluid.
Journal of proteome research 2007;6(7):2859-65.
2007: Komatsu Nahoko; Saijoh Kiyofumi; Kuk Cynthia; Liu Amber C; Khan Saba; Shirasaki Fumiaki; Takehara Kazuhiko; Diamandis Eleftherios P
Human tissue kallikrein expression in the stratum corneum and serum of atopic dermatitis patients.
Experimental dermatology 2007;16(6):513-9.
2007: Diamandis Eleftherios P
Oncopeptidomics: a useful approach for cancer diagnosis?
Clinical chemistry 2007;53(6):1004-6.
2007: Komatsu N; Saijoh K; Kuk C; Shirasaki F; Takehara K; Diamandis E P
Aberrant human tissue kallikrein levels in the stratum corneum and serum of patients with psoriasis: dependence on phenotype, severity and therapy.
The British journal of dermatology 2007;156(5):875-83.
2007: Emami Nashmil; Diamandis Eleftherios P
Human tissue kallikreins: a road under construction.
Clinica chimica acta; international journal of clinical chemistry 2007;381(1):78-84.
2007: Shih Ie-Ming; Salani Ritu; Fiegl Michael; Wang Tian-Li; Soosaipillai Antoninus; Marth Christian; Müller-Holzner Elisabeth; Gastl Gunther; Zhang Zhen; Diamandis Eleftherios P
Ovarian cancer specific kallikrein profile in effusions.
Gynecologic oncology 2007;105(2):501-7.
2007: Memari Nader; Jiang Weiping; Diamandis Eleftherios P; Luo Liu-Ying
Enzymatic properties of human kallikrein-related peptidase 12 (KLK12).
Biological chemistry 2007;388(4):427-35.
2007: Gunawardana C Geeth; Diamandis Eleftherios P
High throughput proteomic strategies for identifying tumour-associated antigens.
Cancer letters 2007;249(1):110-9.
2007: Paliouras Miltiadis; Borgono Carla; Diamandis Eleftherios P
Human tissue kallikreins: the cancer biomarker family.
Cancer letters 2007;249(1):61-79.
2007: Dorn Julia; Schmitt Manfred; Kates Ronald; Schmalfeldt Barbara; Kiechle Marion; Scorilas Andreas; Diamandis Eleftherios P; Harbeck Nadia
Primary tumor levels of human tissue kallikreins affect surgical success and survival in ovarian cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(6):1742-8.
2007: Stephan Carsten; Xu Chuanliang; Cammann Henning; Graefen Markus; Haese Alexander; Huland Hartwig; Semjonow Axel; Diamandis Eleftherios P; Remzi Mesut; Djavan Bob; Wildhagen Mark F; Blijenberg Bert G; Finne Patrik; Stenman Ulf-Hakan; Jung Klaus; Meyer Hellmuth-Alexander
Assay-specific artificial neural networks for five different PSA assays and populations with PSA 2-10 ng/ml in 4,480 men.
World journal of urology 2007;25(1):95-103.
2007: Sardana Girish; Marshall John; Diamandis Eleftherios P
Discovery of candidate tumor markers for prostate cancer via proteomic analysis of cell culture-conditioned medium.
Clinical chemistry 2007;53(3):429-37.
2007: Paliouras Miltiadis; Diamandis Eleftherios P
Coordinated steroid hormone-dependent and independent expression of multiple kallikreins in breast cancer cell lines.
Breast cancer research and treatment 2007;102(1):7-18.
2007: Borgoño Carla A; Michael Iacovos P; Komatsu Nahoko; Jayakumar Arumugam; Kapadia Ravi; Clayman Gary L; Sotiropoulou Georgia; Diamandis Eleftherios P
A potential role for multiple tissue kallikrein serine proteases in epidermal desquamation.
The Journal of biological chemistry 2007;282(6):3640-52.
2007: Komatsu Nahoko; Saijoh Kiyofumi; Otsuki Norio; Kishi Tadaaki; Micheal Iacovos P; Obiezu Christina V; Borgono Carla A; Takehara Kazuhiko; Jayakumar Arumugam; Wu Hua Kang; Clayman Gary L; Diamandis Eleftherios P
Proteolytic processing of human growth hormone by multiple tissue kallikreins and regulation by the serine protease inhibitor Kazal-Type5 (SPINK5) protein.
Clinica chimica acta; international journal of clinical chemistry 2007;377(1-2):228-36.
2007: Shan S J C; Scorilas A; Katsaros D; Diamandis E P
Transcriptional upregulation of human tissue kallikrein 6 in ovarian cancer: clinical and mechanistic aspects.
British journal of cancer 2007;96(2):362-72.
2007: Borgoño Carla A; Michael Iacovos P; Shaw Julie L V; Luo Liu-Ying; Ghosh Manik C; Soosaipillai Antoninus; Grass Linda; Katsaros Dionyssios; Diamandis Eleftherios P
Expression and functional characterization of the cancer-related serine protease, human tissue kallikrein 14.
The Journal of biological chemistry 2007;282(4):2405-22.
2007: Shaw Julie L V; Grass Linda; Sotiropoulou Georgia; Diamandis Eleftherios P
Development of an immunofluorometric assay for human kallikrein 15 (KLK15) and identification of KLK15 in tissues and biological fluids.
Clinical biochemistry 2007;40(1-2):104-10.
2007: van der Merwe Da-Elene; Oikonomopoulou Katerina; Marshall John; Diamandis Eleftherios P
Mass spectrometry: uncovering the cancer proteome for diagnostics.
Advances in cancer research 2007;96():23-50.
2006: Diamandis Eleftherios P
Quality of the scientific literature: all that glitters is not gold.
Clinical biochemistry 2006;39(12):1109-11.
2006: Elliott Marc B; Irwin David M; Diamandis Eleftherios P
In silico identification and Bayesian phylogenetic analysis of multiple new mammalian kallikrein gene families.
Genomics 2006;88(5):591-9.
2006: Shan Shannon J C; Scorilas Andreas; Katsaros Dionyssios; Rigault de la Longrais Irene; Massobrio Marco; Diamandis Eleftherios P
Unfavorable prognostic value of human kallikrein 7 quantified by ELISA in ovarian cancer cytosols.
Clinical chemistry 2006;52(10):1879-86.
2006: Oikonomopoulou Katerina; Hansen Kristina K; Saifeddine Mahmoud; Tea Illa; Blaber Michael; Blaber Sachiko I; Scarisbrick Isobel; Andrade-Gordon Patricia; Cottrell Graeme S; Bunnett Nigel W; Diamandis Eleftherios P; Hollenberg Morley D
Proteinase-activated receptors, targets for kallikrein signaling.
The Journal of biological chemistry 2006;281(43):32095-112.
2006: Komatsu Nahoko; Suga Yasushi; Saijoh Kiyofumi; Liu Amber C; Khan Saba; Mizuno Yuki; Ikeda Shigaku; Wu Hua-Kang; Jayakumar Arumugam; Clayman Gary L; Shirasaki Fumiaki; Takehara Kazuhiko; Diamandis Eleftherios P
Elevated human tissue kallikrein levels in the stratum corneum and serum of peeling skin syndrome-type B patients suggests an over-desquamation of corneocytes.
The Journal of investigative dermatology 2006;126(10):2338-42.
2006: Diamandis Eleftherios P
Peptidomics for cancer diagnosis: present and future.
Journal of proteome research 2006;5(9):2079-82.
2006: Dorn Julia; Harbeck Nadia; Kates Ronald; Magdolen Viktor; Grass Linda; Soosaipillai Antoninus; Schmalfeldt Barbara; Diamandis Eleftherios P; Schmitt Manfred
Disease processes may be reflected by correlations among tissue kallikrein proteases but not with proteolytic factors uPA and PAI-1 in primary ovarian carcinoma.
Biological chemistry 2006;387(8):1121-8.
2006: Slagter Margrita H; Scorilas Andreas; Gooren Louis J G; de Ronde Willem; Soosaipillai Antoninus; Giltay Erik J; Paliouras Miltiadis; Diamandis Eleftherios P
Effect of testosterone administration on serum and urine kallikrein concentrations in female-to-male transsexuals.
Clinical chemistry 2006;52(8):1546-51.
2006: Slagter Margrita H; Gooren Louis J G; Scorilas Andreas; Petraki Constantina D; Diamandis Eleftherios P
Effects of long-term androgen administration on breast tissue of female-to-male transsexuals.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 2006;54(8):905-10.
2006: Parr Ryan L; Dakubo Gabriel D; Crandall Keith A; Maki Jennifer; Reguly Brian; Aguirre Andrea; Wittock Roy; Robinson Kerry; Alexander Jude S; Birch-Machin Mark A; Abdel-Malak Mamdouh; Froberg M Kent; Diamandis Eleftherios P; Thayer Robert E
Somatic mitochondrial DNA mutations in prostate cancer and normal appearing adjacent glands in comparison to age-matched prostate samples without malignant histology.
The Journal of molecular diagnostics : JMD 2006;8(3):312-9.
2006: Slagter Margrita H; Gooren Louis J G; de Ronde Willem; Soosaipillai Antoninus; Scorilas Andreas; Giltay Erik J; Paliouras Miltiadis; Diamandis Eleftherios P
Serum and urine tissue kallikrein concentrations in male-to-female transsexuals treated with antiandrogens and estrogens.
Clinical chemistry 2006;52(7):1356-65.
2006: Oikonomopoulou Katerina; Hansen Kristina K; Saifeddine Mahmoud; Vergnolle Nathalie; Tea Illa; Blaber Michael; Blaber Sachiko I; Scarisbrick Isobel; Diamandis Eleftherios P; Hollenberg Morley D
Kallikrein-mediated cell signalling: targeting proteinase-activated receptors (PARs).
Biological chemistry 2006;387(6):817-24.
2006: Prezas Panagiotis; Arlt Matthias J E; Viktorov Petar; Soosaipillai Antoninus; Holzscheiter Leon; Schmitt Manfred; Talieri Maroulio; Diamandis Eleftherios P; Krüger Achim; Magdolen Viktor
Overexpression of the human tissue kallikrein genes KLK4, 5, 6, and 7 increases the malignant phenotype of ovarian cancer cells.
Biological chemistry 2006;387(6):807-11.
2006: Stephan Carsten; Meyer Hellmuth-Alexander; Cammann Henning; Nakamura Terukazu; Diamandis Eleftherios P; Jung Klaus
Improved prostate cancer detection with a human kallikrein 11 and percentage free PSA-based artificial neural network.
Biological chemistry 2006;387(6):801-5.
2006: Pampalakis Georgios; Diamandis Eleftherios P; Sotiropoulou Georgia
The epigenetic basis for the aberrant expression of kallikreins in human cancers.
Biological chemistry 2006;387(6):795-9.
2006: Obiezu Chistina V; Michael Iacovos P; Levesque Michael A; Diamandis Eleftherios P
Human kallikrein 4: enzymatic activity, inhibition, and degradation of extracellular matrix proteins.
Biological chemistry 2006;387(6):749-59.
2006: Memari Nader; Grass Linda; Nakamura Terukazu; Karakucuk Inci; Diamandis Eleftherios P
Human tissue kallikrein 9: production of recombinant proteins and specific antibodies.
Biological chemistry 2006;387(6):733-40.
2006: Kishi Tadaaki; Cloutier Sylvain M; Kündig Christoph; Deperthes David; Diamandis Eleftherios P
Activation and enzymatic characterization of recombinant human kallikrein 8.
Biological chemistry 2006;387(6):723-31.
2006: Oikonomopoulou Katerina; Hansen Kristina K; Saifeddine Mahmoud; Vergnolle Nathalie; Tea Illa; Diamandis Eleftherios P; Hollenberg Morley D
Proteinase-mediated cell signalling: targeting proteinase-activated receptors (PARs) by kallikreins and more.
Biological chemistry 2006;387(6):677-85.
2006: Petraki Constantina D; Papanastasiou Panagiotis A; Karavana Vassiliki N; Diamandis Eleftherios P
Cellular distribution of human tissue kallikreins: immunohistochemical localization.
Biological chemistry 2006;387(6):653-63.
2006: Paliouras Miltiadis; Diamandis Eleftherios P
The kallikrein world: an update on the human tissue kallikreins.
Biological chemistry 2006;387(6):643-52.
2006: Lundwall Ake; Band Vimla; Blaber Michael; Clements Judith A; Courty Yves; Diamandis Eleftherios P; Fritz Hans; Lilja Hans; Malm Johan; Maltais Lois J; Olsson A Yvonne; Petraki Constantina; Scorilas Andreas; Sotiropoulou Georgia; Stenman Ulf-Håkan; Stephan Carsten; Talieri Maroulio; Yousef George M
A comprehensive nomenclature for serine proteases with homology to tissue kallikreins.
Biological chemistry 2006;387(6):637-41.
2006: Diamandis Eleftherios P
Serum proteomic profiling by matrix-assisted laser desorption-ionization time-of-flight mass spectrometry for cancer diagnosis: next steps.
Cancer research 2006;66(11):5540-1.
2006: Felber Loyse M; Kündig Christoph; Borgoño Carla A; Chagas Jair R; Tasinato Andrea; Jichlinski Patrice; Gygi Christian M; Leisinger Hans-Jürg; Diamandis Eleftherios P; Deperthes David; Cloutier Sylvain M
Mutant recombinant serpins as highly specific inhibitors of human kallikrein 14.
The FEBS journal 2006;273(11):2505-14.
2006: Santin Alessandro D; Diamandis Eleftherios P; Bellone Stefania; Marizzoni Moira; Bandiera Elisabetta; Palmieri Michela; Papasakelariou Catherine; Katsaros Dionyssios; Burnett Alexander; Pecorelli Sergio
Overexpression of kallikrein 10 (hK10) in uterine serous papillary carcinomas.
American journal of obstetrics and gynecology 2006;194(5):1296-302.
2006: Michael Iacovos P; Pampalakis Georgios; Mikolajczyk Stephen D; Malm Johan; Sotiropoulou Georgia; Diamandis Eleftherios P
Human tissue kallikrein 5 is a member of a proteolytic cascade pathway involved in seminal clot liquefaction and potentially in prostate cancer progression.
The Journal of biological chemistry 2006;281(18):12743-50.
2006: Stephan Carsten; Xu Chuanliang; Brown David A; Breit Samuel N; Michael Anja; Nakamura Terukazu; Diamandis Eleftherios P; Meyer Hellmuth; Cammann Henning; Jung Klaus
Three new serum markers for prostate cancer detection within a percent free PSA-based artificial neural network.
The Prostate 2006;66(6):651-9.
2006: Diamandis Eleftherios P
Validation of breast cancer biomarkers identified by mass spectrometry.
Clinical chemistry 2006;52(4):771-2; author reply 772.
2006: Komatsu Nahoko; Tsai Brian; Sidiropoulos Michael; Saijoh Kiyofumi; Levesque Michael A; Takehara Kazuhiko; Diamandis Eleftherios P
Quantification of eight tissue kallikreins in the stratum corneum and sweat.
The Journal of investigative dermatology 2006;126(4):925-9.
2006: Stephan Carsten; Jung Klaus; Nakamura Terukazu; Yousef George M; Kristiansen Glen; Diamandis Eleftherios P
Serum human glandular kallikrein 2 (hK2) for distinguishing stage and grade of prostate cancer.
International journal of urology : official journal of the Japanese Urological Association 2006;13(3):238-43.
2006: Borgoño Carla A; Kishi Tadaaki; Scorilas Andreas; Harbeck Nadia; Dorn Julia; Schmalfeldt Barbara; Schmitt Manfred; Diamandis Eleftherios P
Human kallikrein 8 protein is a favorable prognostic marker in ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(5):1487-93.
2006: Luo Liu-Ying; Shan Shannon J C; Elliott Marc B; Soosaipillai Antoninus; Diamandis Eleftherios P
Purification and characterization of human kallikrein 11, a candidate prostate and ovarian cancer biomarker, from seminal plasma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(3 Pt 1):742-50.
2006: Simon Iris; Zhuo Shaoqiu; Corral Laura; Diamandis Eleftherios P; Sarno Mark J; Wolfert Robert L; Kim Nam W
B7-h4 is a novel membrane-bound protein and a candidate serum and tissue biomarker for ovarian cancer.
Cancer research 2006;66(3):1570-5.
2006: Fritzsche F; Gansukh T; Borgoño C A; Burkhardt M; Pahl S; Mayordomo E; Winzer K-J; Weichert W; Denkert C; Jung K; Stephan C; Dietel M; Diamandis E P; Dahl E; Kristiansen G
Expression of human Kallikrein 14 (KLK14) in breast cancer is associated with higher tumour grades and positive nodal status.
British journal of cancer 2006;94(4):540-7.
2006: Diamandis Eleftherios P
Lost in (the business of) translation: invest in the youth.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(2):669; author reply 669-70.
2006: Brown David A; Stephan Carsten; Ward Robyn L; Law Mathew; Hunter Mark; Bauskin Asne R; Amin Janaki; Jung Klaus; Diamandis Eleftherios P; Hampton Garret M; Russell Pamela J; Giles Graham G; Breit Samuel N
Measurement of serum levels of macrophage inhibitory cytokine 1 combined with prostate-specific antigen improves prostate cancer diagnosis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(1):89-96.
2006: Luo Liu-Ying; Soosaipillai Antoninus; Grass Linda; Diamandis Eleftherios P
Characterization of human kallikreins 6 and 10 in ascites fluid from ovarian cancer patients.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2006;27(5):227-34.
2006: Oikonomopoulou Katerina; Scorilas Andreas; Michael Iacovos P; Grass Linda; Soosaipillai Antoninus; Rosen Barry; Murphy Joan; Diamandis Eleftherios P
Kallikreins as markers of disseminated tumour cells in ovarian cancer-- a pilot study.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2006;27(2):104-14.
2006: Petraki Constantina D; Gregorakis Alkiviadis K; Vaslamatzis Michael M; Papanastasiou Panagiotis A; Yousef George M; Levesque Michael A; Diamandis Eleftherios P
Prognostic implications of the immunohistochemical expression of human kallikreins 5, 6, 10 and 11 in renal cell carcinoma.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2006;27(1):1-7.
2005: Komatsu Nahoko; Saijoh Kiyofumi; Sidiropoulos Michael; Tsai Brian; Levesque Michael A; Elliott Marc B; Takehara Kazuhiko; Diamandis Eleftherios P
Quantification of human tissue kallikreins in the stratum corneum: dependence on age and gender.
The Journal of investigative dermatology 2005;125(6):1182-9.
2005: Sidiropoulos Michael; Pampalakis Georgios; Sotiropoulou Georgia; Katsaros Dionyssios; Diamandis Eleftherios P
Downregulation of human kallikrein 10 (KLK10/NES1) by CpG island hypermethylation in breast, ovarian and prostate cancers.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2005;26(6):324-36.
2005: Rosen Daniel G; Wang Lin; Atkinson J Neeley; Yu Yinhua; Lu Karen H; Diamandis Eleftherios P; Hellstrom Ingegerd; Mok Samuel C; Liu Jinsong; Bast Robert C
Potential markers that complement expression of CA125 in epithelial ovarian cancer.
Gynecologic oncology 2005;99(2):267-77.
2005: Yousef George M; Ejeckam Gershon C; Best Leonico M; Diamandis Eleftherios P
Collecting duct carcinoma associated with oncocytoma.
International braz j urol : official journal of the Brazilian Society of Urology 2005;31(5):465-7; discussion 467-9.
2005: Stephan Carsten; Jung Klaus; Soosaipillai Antoninus; Yousef George M; Cammann Henning; Meyer Hellmuth; Xu Chuanliang; Diamandis Eleftherios P
Clinical utility of human glandular kallikrein 2 within a neural network for prostate cancer detection.
BJU international 2005;96(4):521-7.
2005: Yousef George M; White Nicole M A; Michael Iacovos P; Cho Jane Chan-Kyung; Robb John Desmond; Kurlender Lisa; Khan Saba; Diamandis Eleftherios P
Identification of new splice variants and differential expression of the human kallikrein 10 gene, a candidate cancer biomarker.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2005;26(5):227-35.
2005: Komatsu N; Saijoh K; Toyama T; Ohka R; Otsuki N; Hussack G; Takehara K; Diamandis E P
Multiple tissue kallikrein mRNA and protein expression in normal skin and skin diseases.
The British journal of dermatology 2005;153(2):274-81.
2005: Obiezu Christina V; Shan Shannon J C; Soosaipillai Antoninus; Luo Liu-Ying; Grass Linda; Sotiropoulou Georgia; Petraki Constantina D; Papanastasiou Panos A; Levesque Michael A; Diamandis Eleftherios P
Human kallikrein 4: quantitative study in tissues and evidence for its secretion into biological fluids.
Clinical chemistry 2005;51(8):1432-42.
2005: Obiezu Christina V; Diamandis Eleftherios P
Human tissue kallikrein gene family: applications in cancer.
Cancer letters 2005;224(1):1-22.
2005: Kurlender Lisa; Borgono Carla; Michael Iacovos P; Obiezu Christina; Elliott Marc B; Yousef George M; Diamandis Eleftherios P
A survey of alternative transcripts of human tissue kallikrein genes.
Biochimica et biophysica acta 2005;1755(1):1-14.
2005: Santin Alessandro D; Diamandis Eleftherios P; Bellone Stefania; Soosaipillai Antoninus; Cane Stefania; Palmieri Michela; Burnett Alexander; Roman Juan J; Pecorelli Sergio
Human kallikrein 6: a new potential serum biomarker for uterine serous papillary cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(9):3320-5.
2005: Michael Iacovos P; Sotiropoulou Georgia; Pampalakis Georgios; Magklara Angeliki; Ghosh Manik; Wasney Greg; Diamandis Eleftherios P
Biochemical and enzymatic characterization of human kallikrein 5 (hK5), a novel serine protease potentially involved in cancer progression.
The Journal of biological chemistry 2005;280(15):14628-35.
2005: Felber Loyse M; Borgoño Carla A; Cloutier Sylvain M; Kündig Christoph; Kishi Tadaaki; Ribeiro Chagas Jair; Jichlinski Patrice; Gygi Christian M; Leisinger Hans-Jürg; Diamandis Eleftherios P; Deperthes David
Enzymatic profiling of human kallikrein 14 using phage-display substrate technology.
Biological chemistry 2005;386(3):291-8.
2005: Michael Iacovos P; Kurlender Lisa; Memari Nader; Yousef George M; Du Daisy; Grass Linda; Stephan Carsten; Jung Klaus; Diamandis Eleftherios P
Intron retention: a common splicing event within the human kallikrein gene family.
Clinical chemistry 2005;51(3):506-15.
2005: Diamandis Eleftherios P; van der Merwe Da-Elene
Plasma protein profiling by mass spectrometry for cancer diagnosis: opportunities and limitations.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(3):963-5.
2005: Yousef George M; Obiezu Christina V; Luo Liu-Ying; Magklara Angeliki; Borgoño Carla A; Kishi Tadaaki; Memari Nader; Michael lacovos P; Sidiropoulos Michael; Kurlender Lisa; Economopolou Katerina; Kapadia Carl; Komatsu Nahoko; Petraki Constantina; Elliott Marc; Scorilas Andreas; Katsaros Dionyssios; Levesque Michael A; Diamandis Eleftherios P
Human tissue kallikreins: from gene structure to function and clinical applications.
Advances in clinical chemistry 2005;39():11-79.
2004: Tran Nguyet; Bharaj Bupinder S; Diamandis Eleftherios P; Smith Mylinh; Li Benjamin D L; Yu Herbert
Short tandem repeat polymorphism and cancer risk: influence of laboratory analysis on epidemiologic findings.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2004;13(12):2133-40.
2004: Borgoño Carla A; Diamandis Eleftherios P
The emerging roles of human tissue kallikreins in cancer.
Nature reviews. Cancer 2004;4(11):876-90.
2004: Yousef George M; Borgono Carla A; Michael Iacovos P; Diamandis Eleftherios P
Cloning of a kallikrein pseudogene.
Clinical biochemistry 2004;37(11):961-7.
2004: Kapadia Carl; Ghosh Manik C; Grass Linda; Diamandis Eleftherios P
Human kallikrein 13 involvement in extracellular matrix degradation.
Biochemical and biophysical research communications 2004;323(3):1084-90.
2004: Yousef George M; Borgoño Carla A; White Nicole M A; Robb John-Desmond; Michael Iacovos P; Oikonomopoulou Katerina; Khan Saba; Diamandis Eleftherios P
In silico analysis of the human kallikrein gene 6.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2004;25(5-6):282-9.
2004: Yousef George M; White Nicole M A; Kurlender Lisa; Michael Iacovos; Memari Nader; Robb John-Desmond; Katsaros Dionyssios; Stephan Carsten; Jung Klaus; Diamandis Eleftherios P
The kallikrein gene 5 splice variant 2 is a new biomarker for breast and ovarian cancer.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2004;25(5-6):221-7.
2004: Diamandis Eleftherios P
Proteomic patterns to identify ovarian cancer: 3 years on.
Expert review of molecular diagnostics 2004;4(5):575-7.
2004: Diamandis Eleftherios P; Borgoño Carla A; Scorilas Andreas; Harbeck Nadia; Dorn Julia; Schmitt Manfred
Human kallikrein 11: an indicator of favorable prognosis in ovarian cancer patients.
Clinical biochemistry 2004;37(9):823-9.
2004: Diamandis Eleftherios P
Identification of serum amyloid a protein as a potentially useful biomarker for nasopharyngeal carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(15):5293; author reply 5293-4.
2004: Diamandis Eleftherios P
OvaCheck: doubts voiced soon after publication.
Nature 2004;430(7000):611.
2004: Ghosh Manik C; Grass Linda; Soosaipillai Antoninus; Sotiropoulou Georgia; Diamandis Eleftherios P
Human kallikrein 6 degrades extracellular matrix proteins and may enhance the metastatic potential of tumour cells.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2004;25(4):193-9.
2004: Hoffman Barry R; Diamandis Eleftherios P
Recent advances in cancer biomarkers.
Clinical biochemistry 2004;37(7):503-4.
2004: Pampalakis Georgios; Kurlender Lisa; Diamandis Eleftherios P; Sotiropoulou Georgia
Cloning and characterization of novel isoforms of the human kallikrein 6 gene.
Biochemical and biophysical research communications 2004;320(1):54-61.
2004: Kurlender Lisa; Yousef George M; Memari Nader; Robb John-Desmond; Michael Iacovos P; Borgoño Carla; Katsaros Dionyssios; Stephan Carsten; Jung Klaus; Diamandis Eleftherios P
Differential expression of a human kallikrein 5 (KLK5) splice variant in ovarian and prostate cancer.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2004;25(3):149-56.
2004: Yousef George M; Borgoño Carla A; Michael Iacovos P; Davidian Christine; Stephan Carsten; Jung Klaus; Diamandis Eleftherios P
Molecular cloning of a new gene which is differentially expressed in breast and prostate cancers.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2004;25(3):122-33.
2004: Borgoño Carla A; Michael Iacovos P; Diamandis Eleftherios P
Human tissue kallikreins: physiologic roles and applications in cancer.
Molecular cancer research : MCR 2004;2(5):257-80.
2004: Diamandis Eleftherios P
How are we going to discover new cancer biomarkers? A proteomic approach for bladder cancer.
Clinical chemistry 2004;50(5):793-5.
2004: Diamandis Eleftherios P
Immunoassay interference: a relatively rare but still important problem.
Clinical biochemistry 2004;37(5):331-2.
2004: Yousef George M; Elliott Marc B; Kopolovic Ari D; Serry Eman; Diamandis Eleftherios P
Sequence and evolutionary analysis of the human trypsin subfamily of serine peptidases.
Biochimica et biophysica acta 2004;1698(1):77-86.
2004: Diamandis Eleftherios P; Yousef George M; Olsson A Yvonne
An update on human and mouse glandular kallikreins.
Clinical biochemistry 2004;37(4):258-60.
2004: Diamandis Eleftherios P
Mass spectrometry as a diagnostic and a cancer biomarker discovery tool: opportunities and potential limitations.
Molecular & cellular proteomics : MCP 2004;3(4):367-78.
2004: Kishi Tadaaki; Soosaipillai Antoninus; Grass Linda; Little Sheila P; Johnstone Edward M; Diamandis Eleftherios P
Development of an immunofluorometric assay and quantification of human kallikrein 7 in tissue extracts and biological fluids.
Clinical chemistry 2004;50(4):709-16.
2004: Diamandis Eleftherios P
Analysis of serum proteomic patterns for early cancer diagnosis: drawing attention to potential problems.
Journal of the National Cancer Institute 2004;96(5):353-6.
2004: Diamandis Eleftherios P; Scorilas Andreas; Kishi Tadaaki; Blennow Kaj; Luo Liu-Ying; Soosaipillai Antoninus; Rademaker Alfred W; Sjogren Magnus
Altered kallikrein 7 and 10 concentrations in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia.
Clinical biochemistry 2004;37(3):230-7.
2004: Diamandis Eleftherios P
Re: diagnostic potential of serum proteomic patterns in prostate cancer.
The Journal of urology 2004;171(3):1244-5; author reply 124-5-64.
2004: Papageorgiou Peter C; Pourdjabbar Ali; Amfilochiadis Akis A; Diamandis Eleftherios P; Boomsma Frans; Osmond Daniel H
Are cardiovascular and sympathoadrenal effects of human "new pressor protein" preparations attributable to human coagulation beta-FXIIa?
American journal of physiology. Heart and circulatory physiology 2004;286(3):H837-46.
2004: Scorilas Andreas; Borgoño Carla A; Harbeck Nadia; Dorn Julia; Schmalfeldt Barbara; Schmitt Manfred; Diamandis Eleftherios P
Human kallikrein 13 protein in ovarian cancer cytosols: a new favorable prognostic marker.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(4):678-85.
2004: Sauter Edward R; Lininger John; Magklara Angelika; Hewett John E; Diamandis Eleftherios P
Association of kallikrein expression in nipple aspirate fluid with breast cancer risk.
International journal of cancer. Journal international du cancer 2004;108(4):588-91.
2004: Yousef George M; Borgoño Carla A; Popalis Cynthia; Yacoub George M; Polymeris Mary-Ellen; Soosaipillai Antoninus; Diamandis Eleftherios P
In-silico analysis of kallikrein gene expression in pancreatic and colon cancers.
Anticancer research 2004;24(1):43-51.
2004: Yousef G M; Yacoub G M; Polymeris M-E; Popalis C; Soosaipillai A; Diamandis E P
Kallikrein gene downregulation in breast cancer.
British journal of cancer 2004;90(1):167-72.
2004: Talieri Maroulio; Diamandis Eleftherios P; Gourgiotis Dimitrios; Mathioudaki Kostandina; Scorilas Andreas
Expression analysis of the human kallikrein 7 (KLK7) in breast tumors: a new potential biomarker for prognosis of breast carcinoma.
Thrombosis and haemostasis 2004;91(1):180-6.
2004: Kapadia Carl; Yousef George M; Mellati Ali Awsat; Magklara Angeliki; Wasney Gregory A; Diamandis Eleftherios P
Complex formation between human kallikrein 13 and serum protease inhibitors.
Clinica chimica acta; international journal of clinical chemistry 2004;339(1-2):157-67.
2004: Stephan Carsten; Yousef George M; Scorilas Andreas; Jung Klaus; Jung Monika; Kristiansen Glen; Hauptmann Steffen; Kishi Tadaaki; Nakamura Terukazu; Loening Stefan A; Diamandis Eleftherios P
Hepsin is highly over expressed in and a new candidate for a prognostic indicator in prostate cancer.
The Journal of urology 2004;171(1):187-91.
2004: Sauter Edward R; Klein Gary; Wagner-Mann Colette; Diamandis Eleftherios P
Prostate-specific antigen expression in nipple aspirate fluid is associated with advanced breast cancer.
Cancer detection and prevention 2004;28(1):27-31.
2003: Borgoño Carla A; Grass Linda; Soosaipillai Antoninus; Yousef George M; Petraki Constantina D; Howarth David H C; Fracchioli Stefano; Katsaros Dionyssios; Diamandis Eleftherios P
Human kallikrein 14: a new potential biomarker for ovarian and breast cancer.
Cancer research 2003;63(24):9032-41.
2003: Diamandis Eleftherios P; Borgoño Carla A; Scorilas Andreas; Yousef George M; Harbeck Nadia; Dorn Julia; Schmalfeldt Barbara; Schmitt Manfred
Immunofluorometric quantification of human kallikrein 5 expression in ovarian cancer cytosols and its association with unfavorable patient prognosis.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2003;24(6):299-309.
2003: Luo Liu-Ying; Grass Linda; Diamandis Eleftherios P
Steroid hormone regulation of the human kallikrein 10 (KLK10) gene in cancer cell lines and functional characterization of the KLK10 gene promoter.
Clinica chimica acta; international journal of clinical chemistry 2003;337(1-2):115-26.
2003: Nakamura Terukazu; Scorilas Andreas; Stephan Carsten; Jung Klaus; Soosaipillai Antoninus R; Diamandis Eleftherios P
The usefulness of serum human kallikrein 11 for discriminating between prostate cancer and benign prostatic hyperplasia.
Cancer research 2003;63(19):6543-6.
2003: Yousef George M; Diamandis Eleftherios P
An overview of the kallikrein gene families in humans and other species: emerging candidate tumour markers.
Clinical biochemistry 2003;36(6):443-52.
2003: Yousef George M; Stephan Carsten; Scorilas Andreas; Ellatif Mohamed Abd; Jung Klaus; Kristiansen Glen; Jung Monika; Polymeris Mary-Ellen; Diamandis Eleftherios P
Differential expression of the human kallikrein gene 14 (KLK14) in normal and cancerous prostatic tissues.
The Prostate 2003;56(4):287-92.
2003: Borgoño Carla A; Fracchioli Stefano; Yousef George M; Rigault de la Longrais Irene A; Luo Liu-Ying; Soosaipillai Antoninus; Puopolo Manuela; Grass Linda; Scorilas Andreas; Diamandis Eleftherios P; Katsaros Dionyssios
Favorable prognostic value of tissue human kallikrein 11 (hK11) in patients with ovarian carcinoma.
International journal of cancer. Journal international du cancer 2003;106(4):605-10.
2003: Yousef George M; Scorilas Andreas; Katsaros Dionyssios; Fracchioli Stefano; Iskander Lisa; Borgono Carla; Rigault de la Longrais Irene A; Puopolo Manuela; Massobrio Marco; Diamandis Eleftherios P
Prognostic value of the human kallikrein gene 15 expression in ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(16):3119-26.
2003: Diamandis Eleftherios P
Point: Proteomic patterns in biological fluids: do they represent the future of cancer diagnostics?
Clinical chemistry 2003;49(8):1272-5.
2003: Magklara Angeliki; Mellati Ali A; Wasney Gregory A; Little Sheila P; Sotiropoulou Georgia; Becker Gerald W; Diamandis Eleftherios P
Characterization of the enzymatic activity of human kallikrein 6: Autoactivation, substrate specificity, and regulation by inhibitors.
Biochemical and biophysical research communications 2003;307(4):948-55.
2003: Yousef George M; Kapadia Carl; Polymeris Mary-Ellen; Borgono Carla; Hutchinson Shirley; Wasney Gregory A; Soosaipillai Antoninus; Diamandis Eleftherios P
The human kallikrein protein 5 (hK5) is enzymatically active, glycosylated and forms complexes with two protease inhibitors in ovarian cancer fluids.
Biochimica et biophysica acta 2003;1628(2):88-96.
2003: Yousef George M; Diamandis Eleftherios P
Tissue kallikreins: new players in normal and abnormal cell growth?
Thrombosis and haemostasis 2003;90(1):7-16.
2003: Yousef George M; Polymeris Mary-Ellen; Grass Linda; Soosaipillai Antoninus; Chan Pak-Cheung; Scorilas Andreas; Borgoño Carla; Harbeck Nadia; Schmalfeldt Barbara; Dorn Julia; Schmitt Manfred; Diamandis Eleftherios P
Human kallikrein 5: a potential novel serum biomarker for breast and ovarian cancer.
Cancer research 2003;63(14):3958-65.
2003: Talieri Maroulio; Diamandis Eleftherios P; Katsaros Nikos; Gourgiotis Dimitrios; Scorilas Andreas
Expression of BCL2L12, a new member of apoptosis-related genes, in breast tumors.
Thrombosis and haemostasis 2003;89(6):1081-8.
2003: Kishi Tadaaki; Grass Linda; Soosaipillai Antoninus; Scorilas Andreas; Harbeck Nadia; Schmalfeldt Barbara; Dorn Julia; Mysliwiec Michal; Schmitt Manfred; Diamandis Eleftherios P
Human kallikrein 8, a novel biomarker for ovarian carcinoma.
Cancer research 2003;63(11):2771-4.
2003: Scorilas Andreas; Chiang Pui Ming; Katsaros Dionyssios; Yousef George M; Diamandis Eleftherios P
Molecular characterization of a new gene, CEAL1, encoding for a carcinoembryonic antigen-like protein with a highly conserved domain of eukaryotic translation initiation factors.
Gene 2003;310():79-89.
2003: Nakamura Terukazu; Stephan Carsten; Scorilas Andreas; Yousef George M; Jung Klaus; Diamandis Eleftherios P
Quantitative analysis of hippostasin/KLK11 gene expression in cancerous and noncancerous prostatic tissues.
Urology 2003;61(5):1042-6.
2003: Yousef George M; Kopolovic Ari D; Elliott Marc B; Diamandis Eleftherios P
Genomic overview of serine proteases.
Biochemical and biophysical research communications 2003;305(1):28-36.
2003: Yousef George M; Polymeris Mary-Ellen; Yacoub George M; Scorilas Andreas; Soosaipillai Antoninus; Popalis Cynthia; Fracchioli Stefano; Katsaros Dionyssios; Diamandis Eleftherios P
Parallel overexpression of seven kallikrein genes in ovarian cancer.
Cancer research 2003;63(9):2223-7.
2003: Hutchinson Shirley; Luo Liu-Ying; Yousef George M; Soosaipillai Antoninus; Diamandis Eleftherios P
Purification of human kallikrein 6 from biological fluids and identification of its complex with alpha(1)-antichymotrypsin.
Clinical chemistry 2003;49(5):746-51.
2003: Kollara Alexandra; Diamandis Eleftherios P; Brown Theodore J
Secretion of endogenous kallikreins 2 and 3 by androgen receptor-transfected PC-3 prostate cancer cells.
The Journal of steroid biochemistry and molecular biology 2003;84(5):493-502.
2003: Nakamura T; Scorilas A; Stephan C; Yousef G M; Kristiansen G; Jung K; Diamandis E P
Quantitative analysis of macrophage inhibitory cytokine-1 (MIC-1) gene expression in human prostatic tissues.
British journal of cancer 2003;88(7):1101-4.
2003: Petraki Constantina D; Karavana Vassiliki N; Diamandis Eleftherios P
Human kallikrein 13 expression in normal tissues: an immunohistochemical study.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 2003;51(4):493-501.
2003: Yousef George M; Scorilas Andreas; Nakamura Terukazu; Ellatif Mohamed Abd; Ponzone Riccardo; Biglia Nicoletta; Maggiorotto Furio; Roagna Riccardo; Sismondi Piero; Diamandis Eleftherios P
The prognostic value of the human kallikrein gene 9 (KLK9) in breast cancer.
Breast cancer research and treatment 2003;78(2):149-58.
2003: Yousef George M; Fracchioli Stefano; Scorilas Andreas; Borgoño Carla A; Iskander Lisa; Puopolo Manuela; Massobrio Marco; Diamandis Eleftherios P; Katsaros Dionyssios
Steroid hormone regulation and prognostic value of the human kallikrein gene 14 in ovarian cancer.
American journal of clinical pathology 2003;119(3):346-55.
2003: Diamandis Eleftherios P
Re: Serum proteomic patterns for detection of prostate cancer.
Journal of the National Cancer Institute 2003;95(6):489-90; author reply 490-1.
2003: Diamandis Eleftherios P; Scorilas Andreas; Fracchioli Stefano; Van Gramberen Marleen; De Bruijn Henk; Henrik Alfthan; Soosaipillai Antoninus; Grass Linda; Yousef George M; Stenman Ulf-Hakan; Massobrio Marco; Van Der Zee Ate G J; Vergote Ignace; Katsaros Dionyssios
Human kallikrein 6 (hK6): a new potential serum biomarker for diagnosis and prognosis of ovarian carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(6):1035-43.
2003: Kyriakopoulou Lianna G; Yousef George M; Scorilas Andreas; Katsaros Dionyssios; Massobrio Marco; Fracchioli Stefano; Diamandis Eleftherios P
Prognostic value of quantitatively assessed KLK7 expression in ovarian cancer.
Clinical biochemistry 2003;36(2):135-43.
2003: Yousef George M; Kishi Tadaaki; Diamandis Eleftherios P
Role of kallikrein enzymes in the central nervous system.
Clinica chimica acta; international journal of clinical chemistry 2003;329(1-2):1-8.
2003: Luo Liu-Ying; Katsaros Dionyssios; Scorilas Andreas; Fracchioli Stefano; Bellino Roberto; van Gramberen Marleen; de Bruijn Henk; Henrik Alfthan; Stenman Ulf-Hakan; Massobrio Marco; van der Zee Ate G J; Vergote Ignace; Diamandis Eleftherios P
The serum concentration of human kallikrein 10 represents a novel biomarker for ovarian cancer diagnosis and prognosis.
Cancer research 2003;63(4):807-11.
2003: Scorilas Andreas; Plebani Mario; Mazza Saverio; Basso Daniela; Soosaipillai Antoninus R; Katsaros Nikos; Pagano Francesco; Diamandis Eleftherios P
Serum human glandular kallikrein (hK2) and insulin-like growth factor 1 (IGF-1) improve the discrimination between prostate cancer and benign prostatic hyperplasia in combination with total and %free PSA.
The Prostate 2003;54(3):220-9.
2003: Luo Liu-Ying; Yousef George; Diamandis Eleftherios P
Human tissue kallikreins and testicular cancer.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2003;111(1):225-32; discussion 232-3.
2003: Kishi Tadaaki; Grass Linda; Soosaipillai Antoninus; Shimizu-Okabe Chigusa; Diamandis Eleftherios P
Human kallikrein 8: immunoassay development and identification in tissue extracts and biological fluids.
Clinical chemistry 2003;49(1):87-96.
2003: Kapadia Carl; Chang Albert; Sotiropoulou Georgia; Yousef George M; Grass Linda; Soosaipillai Antoninus; Xing Xuekun; Howarth David H C; Diamandis Eleftherios P
Human kallikrein 13: production and purification of recombinant protein and monoclonal and polyclonal antibodies, and development of a sensitive and specific immunofluorometric assay.
Clinical chemistry 2003;49(1):77-86.
2003: Petraki C D; Gregorakis A K; Papanastasiou P A; Karavana V N; Luo L-Y; Diamandis E P
Immunohistochemical localization of human kallikreins 6, 10 and 13 in benign and malignant prostatic tissues.
Prostate cancer and prostatic diseases 2003;6(3):223-7.
2003: Sotiropoulou Georgia; Rogakos Vassilios; Tsetsenis Theodoros; Pampalakis Georgios; Zafiropoulos Nikolaos; Simillides George; Yiotakis Athanassios; Diamandis Eleftherios P
Emerging interest in the kallikrein gene family for understanding and diagnosing cancer.
Oncology research 2003;13(6-10):381-91.
2002: Yousef G M; Scorilas A; Magklara A; Memari N; Ponzone R; Sismondi P; Biglia N; Abd Ellatif M; Diamandis E P
The androgen-regulated gene human kallikrein 15 (KLK15) is an independent and favourable prognostic marker for breast cancer.
British journal of cancer 2002;87(11):1294-300.
2002: Yousef G M; Borgoño C A; Scorilas A; Ponzone R; Biglia N; Iskander L; Polymeris M-E; Roagna R; Sismondi P; Diamandis E P
Quantitative analysis of human kallikrein gene 14 expression in breast tumours indicates association with poor prognosis.
British journal of cancer 2002;87(11):1287-93.
2002: Yousef George M; Obiezu Christina V; Jung Klaus; Stephan Carsten; Scorilas Andreas; Diamandis Eleftherios P
Differential expression of Kallikrein gene 5 in cancerous and normal testicular tissues.
Urology 2002;60(4):714-8.
2002: Rosenberg Zand Rachel S; Jenkins David J A; Diamandis Eleftherios P
Flavonoids and steroid hormone-dependent cancers.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2002;777(1-2):219-32.
2002: Hoffman B R; Katsaros D; Scorilas A; Diamandis P; Fracchioli S; Rigault de la Longrais I A; Colgan T; Puopolo M; Giardina G; Massobrio M; Diamandis E P
Immunofluorometric quantitation and histochemical localisation of kallikrein 6 protein in ovarian cancer tissue: a new independent unfavourable prognostic biomarker.
British journal of cancer 2002;87(7):763-71.
2002: Petraki Constantina D; Karavana Vassiliki N; Luo Liu-Ying; Diamandis Eleftherios P
Human kallikrein 10 expression in normal tissues by immunohistochemistry.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 2002;50(9):1247-61.
2002: Yousef G M; Diamandis E P
Kallikreins, steroid hormones and ovarian cancer: is there a link?
Minerva endocrinologica 2002;27(3):157-66.
2002: Sauter Edward R; Welch Tamara; Magklara Angeliki; Klein Gary; Diamandis Eleftherios P
Ethnic variation in kallikrein expression in nipple aspirate fluid.
International journal of cancer. Journal international du cancer 2002;100(6):678-82.
2002: Stephan Carsten; Cammann Henning; Semjonow Axel; Diamandis Eleftherios P; Wymenga Leon F A; Lein Michael; Sinha Pranav; Loening Stefan A; Jung Klaus
Multicenter evaluation of an artificial neural network to increase the prostate cancer detection rate and reduce unnecessary biopsies.
Clinical chemistry 2002;48(8):1279-87.
2002: Yousef George M; Scorilas Andreas; Kyriakopoulou Lianna G; Rendl Laura; Diamandis Maria; Ponzone Riccardo; Biglia Nicoletta; Giai Maurizia; Roagna Riccardo; Sismondi Piero; Diamandis Eleftherios P
Human kallikrein gene 5 (KLK5) expression by quantitative PCR: an independent indicator of poor prognosis in breast cancer.
Clinical chemistry 2002;48(8):1241-50.
2002: Obiezu Christina V; Soosaipillai Antoninus; Jung Klaus; Stephan Carsten; Scorilas Andreas; Howarth David H C; Diamandis Eleftherios P
Detection of human kallikrein 4 in healthy and cancerous prostatic tissues by immunofluorometry and immunohistochemistry.
Clinical chemistry 2002;48(8):1232-40.
2002: Diamandis Eleftherios P; Yousef George M
Human tissue kallikreins: a family of new cancer biomarkers.
Clinical chemistry 2002;48(8):1198-205.
2002: Magklara Angeliki; Brown Theodore J; Diamandis Eleftherios P
Characterization of androgen receptor and nuclear receptor co-regulator expression in human breast cancer cell lines exhibiting differential regulation of kallikreins 2 and 3.
International journal of cancer. Journal international du cancer 2002;100(5):507-14.
2002: Yousef George M; Diamandis Eleftherios P
Human tissue kallikreins: a new enzymatic cascade pathway?
Biological chemistry 2002;383(7-8):1045-57.
2002: Luo L-Y; Herrera I; Soosaipillai A; Diamandis E P
Identification of heat shock protein 90 and other proteins as tumour antigens by serological screening of an ovarian carcinoma expression library.
British journal of cancer 2002;87(3):339-43.
2002: Mahmoud Adel A H; Yousef George M; Al-Hifzi Ibrahim; Diamandis Eleftherios P
Cockayne syndrome in three sisters with varying clinical presentation.
American journal of medical genetics 2002;111(1):81-5.
2002: Petraki Constantina D; Karavana Vasso N; Revelos Kyriakos I; Luo Liu-Ying; Diamandis Eleftherios P
Immunohistochemical localization of human kallikreins 6 and 10 in pancreatic islets.
The Histochemical journal 2002;34(6-7):313-22.
2002: Luo L-Y; Diamandis E P; Look M P; Soosaipillai A P; Foekens J A
Higher expression of human kallikrein 10 in breast cancer tissue predicts tamoxifen resistance.
British journal of cancer 2002;86(11):1790-6.
2002: Lin Roberto; Nagai Yoshihiko; Sladek Robert; Bastien Yolande; Ho Joanne; Petrecca Kevin; Sotiropoulou Georgia; Diamandis Eleftherios P; Hudson Thomas J; White John H
Expression profiling in squamous carcinoma cells reveals pleiotropic effects of vitamin D3 analog EB1089 signaling on cell proliferation, differentiation, and immune system regulation.
Molecular endocrinology (Baltimore, Md.) 2002;16(6):1243-56.
2002: Yousef George M; Diamandis Eleftherios P
Expanded human tissue kallikrein family--a novel panel of cancer biomarkers.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2002;23(3):185-92.
2002: Zarghooni Maryam; Soosaipillai Antoninus; Grass Linda; Scorilas Andreas; Mirazimi Nader; Diamandis Eleftherios P
Decreased concentration of human kallikrein 6 in brain extracts of Alzheimer's disease patients.
Clinical biochemistry 2002;35(3):225-31.
2002: Scorilas Andreas; Levesque Michael A; Ashworth Linda K; Diamandis Eleftherios P
Cloning, physical mapping and structural characterization of the human alpha(A)-adaptin gene.
Gene 2002;289(1-2):191-9.
2002: Chang A; Yousef G M; Scorilas A; Grass L; Sismondi P; Ponzone R; Diamandis E P
Human kallikrein gene 13 (KLK13) expression by quantitative RT-PCR: an independent indicator of favourable prognosis in breast cancer.
British journal of cancer 2002;86(9):1457-64.
2002: Diamandis Eleftherios P
Duties and responsibilities of laboratory scientists.
Clinica chimica acta; international journal of clinical chemistry 2002;319(2):111-5.
2002: Yousef George M; Scorilas Andreas; Chang Albert; Rendl Laura; Diamandis Maria; Jung Klaus; Diamandis Eleftherios P
Down-regulation of the human kallikrein gene 5 (KLK5) in prostate cancer tissues.
The Prostate 2002;51(2):126-32.
2002: Bharaj Bhupinder B; Luo Liu-Ying; Jung Klaus; Stephan Carsten; Diamandis Eleftherios P
Identification of single nucleotide polymorphisms in the human kallikrein 10 (KLK10) gene and their association with prostate, breast, testicular, and ovarian cancers.
The Prostate 2002;51(1):35-41.
2002: Soleas George J; Grass Linda; Josephy P David; Goldberg David M; Diamandis Eleftherios P
A comparison of the anticarcinogenic properties of four red wine polyphenols.
Clinical biochemistry 2002;35(2):119-24.
2002: Yousef George M; Ordon Michael H; Foussias George; Diamandis Eleftherios P
Genomic organization of the siglec gene locus on chromosome 19q13.4 and cloning of two new siglec pseudogenes.
Gene 2002;286(2):259-70.
2002: Sauter Edward R; Tichansky David S; Chervoneva Inna; Diamandis Eleftherios P
Circulating testosterone and prostate-specific antigen in nipple aspirate fluid and tissue are associated with breast cancer.
Environmental health perspectives 2002;110(3):241-6.
2002: Rosenberg Zand Rachel S; Jenkins David J A; Brown Theodore J; Diamandis Eleftherios P
Flavonoids can block PSA production by breast and prostate cancer cell lines.
Clinica chimica acta; international journal of clinical chemistry 2002;317(1-2):17-26.
2002: Stephan Carsten; Jung Klaus; Diamandis Eleftherios P; Rittenhouse Harry G; Lein Michael; Loening Stefan A
Prostate-specific antigen, its molecular forms, and other kallikrein markers for detection of prostate cancer.
Urology 2002;59(1):2-8.
2002: Diamandis Eleftherios P; Okui Akira; Mitsui Shinichii; Luo Liu-Ying; Soosaipillai Antoninus; Grass Linda; Nakamura Terukazu; Howarth David J C; Yamaguchi Nozomi
Human kallikrein 11: a new biomarker of prostate and ovarian carcinoma.
Cancer research 2002;62(1):295-300.
2002: Sauter Edward R; Chervoneva Inna; Diamandis Anastasia; Khosravi Javad M; Litwin Samuel; Diamandis Eleftherios P
Prostate-specific antigen and insulin-like growth factor binding protein-3 in nipple aspirate fluid are associated with breast cancer.
Cancer detection and prevention 2002;26(2):149-57.
2001: Yousef G M; Kyriakopoulou L G; Scorilas A; Fracchioli S; Ghiringhello B; Zarghooni M; Chang A; Diamandis M; Giardina G; Hartwick W J; Richiardi G; Massobrio M; Diamandis E P; Katsaros D
Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: a new independent and favorable prognostic marker.
Cancer research 2001;61(21):7811-8.
2001: Petraki C D; Karavana V N; Skoufogiannis P T; Little S P; Howarth D J; Yousef G M; Diamandis E P
The spectrum of human kallikrein 6 (zyme/protease M/neurosin) expression in human tissues as assessed by immunohistochemistry.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 2001;49(11):1431-41.
2001: Rosenberg Zand R S; Jenkins D J; Diamandis E P
Effects of natural products and nutraceuticals on steroid hormone-regulated gene expression.
Clinica chimica acta; international journal of clinical chemistry 2001;312(1-2):213-9.
2001: Chang A; Yousef G M; Jung K; Rajpert-De Meyts E; Diamandis E P
Identification and molecular characterization of five novel kallikrein gene 13 (KLK13; KLK-L4) splice variants: differential expression in the human testis and testicular cancer.
Anticancer research 2001;21(5):3147-52.
2001: Obiezu C V; Scorilas A; Katsaros D; Massobrio M; Yousef G M; Fracchioli S; Rigault de la Longrais I A; Arisio R; Diamandis E P
Higher human kallikrein gene 4 (KLK4) expression indicates poor prognosis of ovarian cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(8):2380-6.
2001: Luo L Y; Katsaros D; Scorilas A; Fracchioli S; Piccinno R; Rigault de la Longrais I A; Howarth D J; Diamandis E P
Prognostic value of human kallikrein 10 expression in epithelial ovarian carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(8):2372-9.
2001: Sidiropoulos M; Chang A; Jung K; Diamandis E P
Expression and regulation of prostate androgen regulated transcript-1 (PART-1) and identification of differential expression in prostatic cancer.
British journal of cancer 2001;85(3):393-7.
2001: Yousef G M; Bharaj B S; Yu H; Poulopoulos J; Diamandis E P
Sequence analysis of the human kallikrein gene locus identifies a unique polymorphic minisatellite element.
Biochemical and biophysical research communications 2001;285(5):1321-9.
2001: Diamandis E P; Yousef G M
Human tissue kallikrein gene family: a rich source of novel disease biomarkers.
Expert review of molecular diagnostics 2001;1(2):182-90.
2001: Soleas G J; Goldberg D M; Grass L; Levesque M; Diamandis E P
Do wine polyphenols modulate p53 gene expression in human cancer cell lines?
Clinical biochemistry 2001;34(5):415-20.
2001: Luo L Y; Rajpert-De Meyts E R; Jung K; Diamandis E P
Expression of the normal epithelial cell-specific 1 (NES1; KLK10) candidate tumour suppressor gene in normal and malignant testicular tissue.
British journal of cancer 2001;85(2):220-4.
2001: Scorilas A; Kyriakopoulou L; Katsaros D; Diamandis E P
Cloning of a gene (SR-A1), encoding for a new member of the human Ser/Arg-rich family of pre-mRNA splicing factors: overexpression in aggressive ovarian cancer.
British journal of cancer 2001;85(2):190-8.
2001: Scorilas A; Yousef G M; Jung K; Rajpert-De Meyts E; Carsten S; Diamandis E P
Identification and characterization of a novel human testis-specific kinase substrate gene which is downregulated in testicular tumors.
Biochemical and biophysical research communications 2001;285(2):400-8.
2001: Yousef G M; Diamandis M; Jung K; Diamandis E P
Molecular cloning of a novel human acid phosphatase gene (ACPT) that is highly expressed in the testis.
Genomics 2001;74(3):385-95.
2001: Yousef G M; Ordon M H; Foussias G; Diamandis E P
Molecular characterization, tissue expression, and mapping of a novel Siglec-like gene (SLG2) with three splice variants.
Biochemical and biophysical research communications 2001;284(4):900-10.
2001: Foussias G; Taylor S M; Yousef G M; Tropak M B; Ordon M H; Diamandis E P
Cloning and molecular characterization of two splice variants of a new putative member of the Siglec-3-like subgroup of Siglecs.
Biochemical and biophysical research communications 2001;284(4):887-99.
2001: Magklara A; Scorilas A; Katsaros D; Massobrio M; Yousef G M; Fracchioli S; Danese S; Diamandis E P
The human KLK8 (neuropsin/ovasin) gene: identification of two novel splice variants and its prognostic value in ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(4):806-11.
2001: Yousef G M; Magklara A; Chang A; Jung K; Katsaros D; Diamandis E P
Cloning of a new member of the human kallikrein gene family, KLK14, which is down-regulated in different malignancies.
Cancer research 2001;61(8):3425-31.
2001: Obiezu C V; Scorilas A; Magklara A; Thornton M H; Wang C Y; Stanczyk F Z; Diamandis E P
Prostate-specific antigen and human glandular kallikrein 2 are markedly elevated in urine of patients with polycystic ovary syndrome.
The Journal of clinical endocrinology and metabolism 2001;86(4):1558-61.
2001: Yousef G M; Diamandis E P
The new human tissue kallikrein gene family: structure, function, and association to disease.
Endocrine reviews 2001;22(2):184-204.
2001: Luo L Y; Bunting P; Scorilas A; Diamandis E P
Human kallikrein 10: a novel tumor marker for ovarian carcinoma?
Clinica chimica acta; international journal of clinical chemistry 2001;306(1-2):111-8.
2001: Scorilas A; Kyriakopoulou L; Yousef G M; Ashworth L K; Kwamie A; Diamandis E P
Molecular cloning, physical mapping, and expression analysis of a novel gene, BCL2L12, encoding a proline-rich protein with a highly conserved BH2 domain of the Bcl-2 family.
Genomics 2001;72(2):217-21.
2001: Katsaros D; Yu H; Levesque M A; Danese S; Genta F; Richiardi G; Fracchioli S; Khosravi M J; Diamandi A; Gordini G; Diamandis E P; Massobrio M
IGFBP-3 in epithelial ovarian carcinoma and its association with clinico-pathological features and patient survival.
European journal of cancer (Oxford, England : 1990) 2001;37(4):478-85.
2001: Scorilas A; Bharaj B; Giai M; Diamandis E P
Codon 89 polymorphism in the human 5 alpha-reductase gene in primary breast cancer.
British journal of cancer 2001;84(6):760-7.
2001: Kim H; Scorilas A; Katsaros D; Yousef G M; Massobrio M; Fracchioli S; Piccinno R; Gordini G; Diamandis E P
Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer.
British journal of cancer 2001;84(5):643-50.
2001: Luo L Y; Grass L; Howarth D J; Thibault P; Ong H; Diamandis E P
Immunofluorometric assay of human kallikrein 10 and its identification in biological fluids and tissues.
Clinical chemistry 2001;47(2):237-46.
2001: Luo L Y; Soosaipillai A; Diamandis E P
Molecular cloning of a novel human gene on chromosome 4p11 by immunoscreening of an ovarian carcinoma cDNA library.
Biochemical and biophysical research communications 2001;280(1):401-6.
2001: Yousef G M; Scorilas A; Jung K; Ashworth L K; Diamandis E P
Molecular cloning of the human kallikrein 15 gene (KLK15). Up-regulation in prostate cancer.
The Journal of biological chemistry 2001;276(1):53-61.
2001: Soleas G J; Diamandis E P; Goldberg D M
The world of resveratrol.
Advances in experimental medicine and biology 2001;492():159-82.
2001: Soleas G J; Angelini M; Grass L; Diamandis E P; Goldberg D M
Absorption of trans-resveratrol in rats.
Methods in enzymology 2001;335():145-54.
2000: Diamandis E P; Yousef G M; Petraki C; Soosaipillai A R
Human kallikrein 6 as a biomarker of alzheimer's disease.
Clinical biochemistry 2000;33(8):663-7.
2000: Luo L Y; Diamandis E P
Preliminary examination of time-resolved fluorometry for protein array applications.
Luminescence : the journal of biological and chemical luminescence 2000;15(6):409-13.
2000: Scorilas A; Black M H; Talieri M; Diamandis E P
Genomic organization, physical mapping, and expression analysis of the human protein arginine methyltransferase 1 gene.
Biochemical and biophysical research communications 2000;278(2):349-59.
2000: Foussias G; Yousef G M; Diamandis E P
Molecular characterization of a Siglec8 variant containing cytoplasmic tyrosine-based motifs, and mapping of the Siglec8 gene.
Biochemical and biophysical research communications 2000;278(3):775-81.
2000: Diamandis E P; Yousef G M; Clements J; Ashworth L K; Yoshida S; Egelrud T; Nelson P S; Shiosaka S; Little S; Lilja H; Stenman U H; Rittenhouse H G; Wain H
New nomenclature for the human tissue kallikrein gene family.
Clinical chemistry 2000;46(11):1855-8.
2000: Yousef G M; Magklara A; Diamandis E P
KLK12 is a novel serine protease and a new member of the human kallikrein gene family-differential expression in breast cancer.
Genomics 2000;69(3):331-41.
2000: Obiezu C V; Diamandis E P
An alternatively spliced variant of KLK4 expressed in prostatic tissue.
Clinical biochemistry 2000;33(7):599-600.
2000: Diamandis E P; Yousef G M; Soosaipillai A R; Bunting P
Human kallikrein 6 (zyme/protease M/neurosin): a new serum biomarker of ovarian carcinoma.
Clinical biochemistry 2000;33(7):579-83.
2000: Magklara A; Cheung C C; Asa S L; Diamandis E P
Expression of prostate-specific antigen and human glandular kallikrein 2 in the thyroid gland.
Clinica chimica acta; international journal of clinical chemistry 2000;300(1-2):171-80.
2000: Yousef G M; Chang A; Scorilas A; Diamandis E P
Genomic organization of the human kallikrein gene family on chromosome 19q13.3-q13.4.
Biochemical and biophysical research communications 2000;276(1):125-33.
2000: Scorilas A; Bjartell A; Lilja H; Moller C; Diamandis E P
Streptavidin-polyvinylamine conjugates labeled with a europium chelate: applications in immunoassay, immunohistochemistry, and microarrays.
Clinical chemistry 2000;46(9):1450-5.
2000: Magklara A; Scorilas A; Stephan C; Kristiansen G O; Hauptmann S; Jung K; Diamandis E P
Decreased concentrations of prostate-specific antigen and human glandular kallikrein 2 in malignant versus nonmalignant prostatic tissue.
Urology 2000;56(3):527-32.
2000: Yousef G M; Scorilas A; Magklara A; Soosaipillai A; Diamandis E P
The KLK7 (PRSS6) gene, encoding for the stratum corneum chymotryptic enzyme is a new member of the human kallikrein gene family - genomic characterization, mapping, tissue expression and hormonal regulation.
Gene 2000;254(1-2):119-28.
2000: Levesque M A; Katsaros D; Massobrio M; Genta F; Yu H; Richiardi G; Fracchioli S; Durando A; Arisio R; Diamandis E P
Evidence for a dose-response effect between p53 (but not p21WAF1/Cip1) protein concentrations, survival, and responsiveness in patients with epithelial ovarian cancer treated with platinum-based chemotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(8):3260-70.
2000: Diamandis E P; Yousef G M; Soosaipillai A R; Grass L; Porter A; Little S; Sotiropoulou G
Immunofluorometric assay of human kallikrein 6 (zyme/protease M/neurosin) and preliminary clinical applications.
Clinical biochemistry 2000;33(5):369-75.
2000: Scorilas A; Diamandis E P
Polyvinylamine-streptavidin complexes labeled with a europium chelator: a universal detection reagent for solid-phase time resolved fluorometric applications.
Clinical biochemistry 2000;33(5):345-50.
2000: Zand R S; Jenkins D J; Diamandis E P
Steroid hormone activity of flavonoids and related compounds.
Breast cancer research and treatment 2000;62(1):35-49.
2000: Foussias G; Yousef G M; Diamandis E P
Identification and molecular characterization of a novel member of the siglec family (SIGLEC9).
Genomics 2000;67(2):171-8.
2000: Diamandis E P
Prostate-specific antigen: a cancer fighter and a valuable messenger?
Clinical chemistry 2000;46(7):896-900.
2000: Obiezu C V; Giltay E J; Magklara A; Scorilas A; Gooren L J; Yu H; Howarth D J; Diamandis E P
Serum and urinary prostate-specific antigen and urinary human glandular kallikrein concentrations are significantly increased after testosterone administration in female-to-male transsexuals.
Clinical chemistry 2000;46(6 Pt 1):859-62.
2000: Bharaj B; Scorilas A; Diamandis E P; Giai M; Levesque M A; Sutherland D J; Hoffman B R
Breast cancer prognostic significance of a single nucleotide polymorphism in the proximal androgen response element of the prostate specific antigen gene promoter.
Breast cancer research and treatment 2000;61(2):111-9.
2000: Obiezu C V; Yousef G; Diamandis E P
Identification of exon 1 of prostase/KLK-L1 gene.
Clinical biochemistry 2000;33(3):221-2.
2000: Bharaj B; Scorilas A; Giai M; Diamandis E P
TA repeat polymorphism of the 5alpha-reductase gene and breast cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2000;9(4):387-93.
2000: Yousef G M; Diamandis E P
The expanded human kallikrein gene family: locus characterization and molecular cloning of a new member, KLK-L3 (KLK9).
Genomics 2000;65(2):184-94.
2000: Yousef G M; Chang A; Diamandis E P
Identification and characterization of KLK-L4, a new kallikrein-like gene that appears to be down-regulated in breast cancer tissues.
The Journal of biological chemistry 2000;275(16):11891-8.
2000: Rosenberg Zand R S; Grass L; Magklara A; Jenkins D J; Diamandis E P
Is ICI 182,780 an antiprogestin in addition to being an antiestrogen?
Breast cancer research and treatment 2000;60(1):1-8.
2000: Luo L Y; Grass L; Diamandis E P
The normal epithelial cell-specific 1 (NES1) gene is up-regulated by steroid hormones in the breast carcinoma cell line BT-474.
Anticancer research 2000;20(2A):981-6.
2000: Vassilikos E J; Yu H; Trachtenberg J; Nam R K; Narod S A; Bromberg I L; Diamandis E P
Relapse and cure rates of prostate cancer patients after radical prostatectomy and 5 years of follow-up.
Clinical biochemistry 2000;33(2):115-23.
2000: Obiezu C V; Giltay E J; Magklara A; Scorilas A; Gooren L; Yu H; Diamandis E P
Dramatic suppression of plasma and urinary prostate specific antigen and human glandular kallikrein by antiandrogens in male-to-female transsexuals.
The Journal of urology 2000;163(3):802-5.
2000: Diamandis E P; Yousef G M; Luo L Y; Magklara A; Obiezu C V
The new human kallikrein gene family: implications in carcinogenesis.
Trends in endocrinology and metabolism: TEM 2000;11(2):54-60.
2000: Magklara A; Grass L; Diamandis E P
Differential steroid hormone regulation of human glandular kallikrein (hK2) and prostate-specific antigen (PSA) in breast cancer cell lines.
Breast cancer research and treatment 2000;59(3):263-70.
2000: Angelopoulou K; Yu H; Bharaj B; Giai M; Diamandis E P
p53 gene mutation, tumor p53 protein overexpression, and serum p53 autoantibody generation in patients with breast cancer.
Clinical biochemistry 2000;33(1):53-62.
2000: Black M H; Giai M; Ponzone R; Sismondi P; Yu H; Diamandis E P
Serum total and free prostate-specific antigen for breast cancer diagnosis in women.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(2):467-73.
2000: Scorilas A; Yu H; Soosaipillai A R; Gregorakis A K; Diamandis E P
Comparison of the percent free prostate-specific antigen levels in the serum of healthy men and in men with recurrent prostate cancer after radical prostatectomy.
Clinica chimica acta; international journal of clinical chemistry 2000;292(1-2):127-38.
2000: Yu H; Bharaj B; Vassilikos E J; Giai M; Diamandis E P
Shorter CAG repeat length in the androgen receptor gene is associated with more aggressive forms of breast cancer.
Breast cancer research and treatment 2000;59(2):153-61.
2000: Black M H; Diamandis E P
The diagnostic and prognostic utility of prostate-specific antigen for diseases of the breast.
Breast cancer research and treatment 2000;59(1):1-14.
2000: Yousef G M; Scorilas A; Diamandis E P
Genomic organization, mapping, tissue expression, and hormonal regulation of trypsin-like serine protease (TLSP PRSS20), a new member of the human kallikrein gene family.
Genomics 2000;63(1):88-96.
2000: Black M H; Magklara A; Obiezu C; Levesque M A; Sutherland D J; Tindall D J; Young C Y; Sauter E R; Diamandis E P
Expression of a prostate-associated protein, human glandular kallikrein (hK2), in breast tumours and in normal breast secretions.
British journal of cancer 2000;82(2):361-7.
2000: Levesque M A; D'Costa M; Diamandis E P
p21WAF1 protein expression determined by quantitative immunoassay in relation to non-small-cell lung cancer aggressiveness.
Journal of cancer research and clinical oncology 2000;126(1):48-52.
1999: Yousef G M; Luo L Y; Scherer S W; Sotiropoulou G; Diamandis E P
Molecular characterization of zyme/protease M/neurosin (PRSS9), a hormonally regulated kallikrein-like serine protease.
Genomics 1999;62(2):251-9.
1999: Yousef G M; Diamandis E P
The new kallikrein-like gene, KLK-L2. Molecular characterization, mapping, tissue expression, and hormonal regulation.
The Journal of biological chemistry 1999;274(53):37511-6.
1999: Magklara A; Scorilas A; Catalona W J; Diamandis E P
The combination of human glandular kallikrein and free prostate-specific antigen (PSA) enhances discrimination between prostate cancer and benign prostatic hyperplasia in patients with moderately increased total PSA.
Clinical chemistry 1999;45(11):1960-6.
1999: Angelopoulou K; Borchert G; Melegos D N; Lianidou E; Lilja H; Diamandis E P
Characterization of the BRCA1-like immunoreactivity of human seminal plasma.
Urology 1999;54(4):753-62.
1999: Magklara A; Scorilas A; López-Otín C; Vizoso F; Ruibal A; Diamandis E P
Human glandular kallikrein in breast milk, amniotic fluid, and breast cyst fluid.
Clinical chemistry 1999;45(10):1774-80.
1999: Yu H; Levesque M A; Clark G M; Diamandis E P
Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination.
British journal of cancer 1999;81(3):490-5.
1999: Yousef G M; Obiezu C V; Luo L Y; Black M H; Diamandis E P
Prostase/KLK-L1 is a new member of the human kallikrein gene family, is expressed in prostate and breast tissues, and is hormonally regulated.
Cancer research 1999;59(17):4252-6.
1999: Yousef G M; Luo L Y; Diamandis E P
Identification of novel human kallikrein-like genes on chromosome 19q13.3-q13.4.
Anticancer research 1999;19(4B):2843-52.
1999: Bharaj B S; Vassilikos E J; Diamandis E P
Rapid and accurate determination of (CAG)n repeats in the androgen receptor gene using polymerase chain reaction and automated fragment analysis.
Clinical biochemistry 1999;32(5):327-32.
1999: Scorilas A; Diamandis E P; Levesque M A; Papanastasiou-Diamandi A; Khosravi M J; Giai M; Ponzone R; Roagna R; Sismondi P; López-Otin C
Immunoenzymatically determined pepsinogen C concentration in breast tumor cytosols: an independent favorable prognostic factor in node-positive patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(7):1778-85.
1999: Black M H; Magklara A; Obiezu C V; Melegos D N; Diamandis E P
Development of an ultrasensitive immunoassay for human glandular kallikrein with no cross-reactivity from prostate-specific antigen.
Clinical chemistry 1999;45(6 Pt 1):790-9.
1999: Majumdar S; Diamandis E P
The promoter and the enhancer region of the KLK 3 (prostate specific antigen) gene is frequently mutated in breast tumours and in breast carcinoma cell lines.
British journal of cancer 1999;79(9-10):1594-602.
1999: Diamandis E P; Arnett W P; Foussias G; Pappas H; Ghandi S; Melegos D N; Mullen B; Yu H; Srigley J; Jarvi K
Seminal plasma biochemical markers and their association with semen analysis findings.
Urology 1999;53(3):596-603.
1999: Jenkins D J; Kendall C W; Vidgen E; Agarwal S; Rao A V; Rosenberg R S; Diamandis E P; Novokmet R; Mehling C C; Perera T; Griffin L C; Cunnane S C
Health aspects of partially defatted flaxseed, including effects on serum lipids, oxidative measures, and ex vivo androgen and progestin activity: a controlled crossover trial.
The American journal of clinical nutrition 1999;69(3):395-402.
1999: Black M H; Grass C L; Leinonen J; Stenman U H; Diamandis E P
Characterization of monoclonal antibodies for prostate-specific antigen and development of highly sensitive free prostate-specific antigen assays.
Clinical chemistry 1999;45(3):347-54.
1999: Diamandis E P; Helle S I; Yu H; Melegos D N; Lundgren S; Lonning P E
Prognostic value of plasma prostate specific antigen after megestrol acetate treatment in patients with metastatic breast carcinoma.
Cancer 1999;85(4):891-8.
1999: Borchert G H; Melegos D N; Yu H; Giai M; Roagna R; Ponzone R; Sgro L; Diamandis E P
Quantification of pepsinogen C and prostaglandin D synthase in breast cyst fluid and their potential utility for cyst type classification.
Clinical biochemistry 1999;32(1):39-44.
1999: Foekens J A; Diamandis E P; Yu H; Look M P; Meijer-van Gelder M E; van Putten W L; Klijn J G
Expression of prostate-specific antigen (PSA) correlates with poor response to tamoxifen therapy in recurrent breast cancer.
British journal of cancer 1999;79(5-6):888-94.
1999: Lianidou E S; Levesque M A; Katsaros D; Angelopoulou K; Yu H; Genta F; Arisio R; Massobrio M; Bharaj B; Diamandis E P
Immunofluorometric assay of p53 protein versus sequencing of p53 exons 5 to 9 for the detection of p53 abnormalities in ovarian carcinoma.
Anticancer research 1999;19(1B):749-56.
1999: Melegos D N; Grass L; Pierratos A; Diamandis E P
Highly elevated levels of prostaglandin D synthase in the serum of patients with renal failure.
Urology 1999;53(1):32-7.
1999: Rosenberg Zand R S; Jenkins D J; Diamandis E P
Development and evaluation of a competitive time-resolved immunofluorometric assay for the estrogen-regulated protein pS2.
Journal of clinical laboratory analysis 1999;13(5):241-5.
1999: Borchert G H; Yu H; Tomlinson G; Giai M; Roagna R; Ponzone R; Sgro L; Diamandis E P
Prostate specific antigen molecular forms in breast cyst fluid and serum of women with fibrocystic breast disease.
Journal of clinical laboratory analysis 1999;13(2):75-81.
1999: Luo L; Diamandis E P
Amplification of human genomic DNA sequences with polymerase chain reaction using a single oligonucleotide primer.
Journal of clinical laboratory analysis 1999;13(2):69-74.
1998: Yu H; Levesque M A; Khosravi M J; Papanastasiou-Diamandi A; Clark G M; Diamandis E P
Insulin-like growth factor-binding protein-3 and breast cancer survival.
International journal of cancer. Journal international du cancer 1998;79(6):624-8.
1998: Angelopoulou K; Prody C; Diamandis E P
A candidate new gene on human chromosome 5q12 contains a motif that is found in transcriptional co-activators.
Clinical biochemistry 1998;31(8):687-8.
1998: Diamandis E P
Prostate-specific Antigen: Its Usefulness in Clinical Medicine.
Trends in endocrinology and metabolism: TEM 1998;9(8):310-6.
1998: Lianidou E S; Angelopoulou K; Katsaros D; Durando A; Massobrio M; Diamandis E P;
Fragment analysis of the p53 gene in ovarian tumors.
Clinical biochemistry 1998;31(7):551-3.
1998: Levesque M A; D'Costa M; Spratt E H; Yaman M M; Diamandis E P
Quantitative analysis of p53 protein in non-small cell lung cancer and its prognostic value.
International journal of cancer. Journal international du cancer 1998;79(5):494-501.
1998: Levesque M A; Yu H; Clark G M; Diamandis E P
Enzyme-linked immunoabsorbent assay-detected p53 protein accumulation: a prognostic factor in a large breast cancer cohort.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(8):2641-50.
1998: Rosenberg R S; Grass L; Jenkins D J; Kendall C W; Diamandis E P
Modulation of androgen and progesterone receptors by phytochemicals in breast cancer cell lines.
Biochemical and biophysical research communications 1998;248(3):935-9.
1998: Bharaj B S; Angelopoulou K; Diamandis E P
Rapid sequencing of the p53 gene with a new automated DNA sequencer.
Clinical chemistry 1998;44(7):1397-403.
1998: Luo L; Herbrick J A; Scherer S W; Beatty B; Squire J; Diamandis E P
Structural characterization and mapping of the normal epithelial cell-specific 1 gene.
Biochemical and biophysical research communications 1998;247(3):580-6.
1998: Katsaros D; Melegos D N; Diamandis E P
Prostate specific antigen production by breast tumors after induction with oral contraceptives.
Clinical biochemistry 1998;31(4):285-8.
1998: Levesque M A; Katsaros D; Yu H; Giai M; Genta F; Roagna R; Ponzone R; Massobrio M; Sismondi P; Diamandis E P
Immunofluorometrically determined p53 accumulation as a prognostic indicator in Italian breast cancer patients.
International journal of cancer. Journal international du cancer 1998;79(2):147-52.
1998: Kogan I; Ballinger J R; Redshaw R; Diamandis E P; Melegos D N; Kuba R M; Rauth A M
Prostate-specific antigen induction by a steroid hormone in T47D cells growing in SCID mice.
Breast cancer research and treatment 1998;48(1):73-80.
1998: Lambert-Messerlian G M; Canick J A; Melegos D N; Diamandis E P
Increased concentrations of prostate-specific antigen in maternal serum from pregnancies affected by fetal Down syndrome.
Clinical chemistry 1998;44(2):205-8.
1998: Angelopoulou K; Levesque M A; Katsaros D; Shipman R; Diamandis E P
Exon 5 of the p53 gene is a target for deletions in ovarian cancer.
Clinical chemistry 1998;44(1):72-7.
1998: Angelopoulou K; Diamandis E P
Identification of deletions and insertions in the p53 gene using multiplex PCR and high-resolution fragment analysis: application to breast and ovarian tumors.
Journal of clinical laboratory analysis 1998;12(4):250-6.
1998: Randell E; Diamandis E P; Goldberg D M
Changes in serum carbohydrate-deficient transferrin and gammaglutamyl transferase after moderate wine consumption in healthy males.
Journal of clinical laboratory analysis 1998;12(2):92-7.
1998: Diamandis E P
Prostate-specific antigen or human kallikrein 3? Recent developments.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1998;19(2):65-7; discussion 67-8.
1997: Tsuyuki D; Grass L; Diamandis E P
Frequent detection of mutations in the 5' flanking region of the prostate-specific antigen gene in female breast cancer.
European journal of cancer (Oxford, England : 1990) 1997;33(11):1851-4.
1997: Zarghami N; Grass L; Sauter E R; Diamandis E P
Prostate-specific antigen in serum during the menstrual cycle.
Clinical chemistry 1997;43(10):1862-7.
1997: Diamandis E P; Nadkarni S; Bhaumik B; Abdelrahman A; Melegos D N; Borchert G; Black M H; Alonso M; Salas A; de los Toyos J R; Sampedro A; López-Otín C
Immunofluorometric assay of pepsinogen C and preliminary clinical applications.
Clinical chemistry 1997;43(8 Pt 1):1365-71.
1997: Zarghami N; Levesque M; D'Costa M; Angelopoulou K; Diamandis E P
Frequency of expression of prostate-specific antigen mRNA in lung tumors.
American journal of clinical pathology 1997;108(2):184-90.
1997: Zarghami N; D'Costa M; Tsuyuki D; Asa S L; Diamandis E P
Expression of the prostate specific antigen gene by lung tissue.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(7):1201-6.
1997: Melegos D N; Freedman M S; Diamandis E P
Prostaglandin D synthase concentration in cerebrospinal fluid and serum of patients with neurological disorders.
Prostaglandins 1997;54(1):463-74.
1997: Lianidou E S; Melegos D N; Diamandis E P
BRCA1 tumor suppressor gene product shares immunoreactive epitopes with a protein present in seminal plasma.
Clinical biochemistry 1997;30(5):425-32.
1997: Melegos D N; Freedman M S; Diamandis E P
Prostate-specific antigen in cerebrospinal fluid.
Clinical chemistry 1997;43(5):855.
1997: Diamandis E P; Yu H
Nonprostatic sources of prostate-specific antigen.
The Urologic clinics of North America 1997;24(2):275-82.
1997: Borchert G H; Giai M; Diamandis E P
Elevated levels of prostate-specific antigen in serum of women with fibroadenomas and breast cysts.
Journal of the National Cancer Institute 1997;89(8):587-8.
1997: Soleas G J; Diamandis E P; Goldberg D M
Resveratrol: a molecule whose time has come? And gone?
Clinical biochemistry 1997;30(2):91-113.
1997: Yu H; Diamandis E P; Wong P Y; Nam R; Trachtenberg J
Detection of prostate cancer relapse with prostate specific antigen monitoring at levels of 0.001 to 0.1 microG./L.
The Journal of urology 1997;157(3):913-8.
1997: Melegos D N; Yu H; Ashok M; Wang C; Stanczyk F; Diamandis E P
Prostate-specific antigen in female serum, a potential new marker of androgen excess.
The Journal of clinical endocrinology and metabolism 1997;82(3):777-80.
1997: Levesque M A; Tadross L; Diamandis E P; D'Costa M
Comparison of immunofluorometry and immunohistochemistry for the detection of p53 protein in lung cancer specimens.
American journal of clinical pathology 1997;107(3):308-16.
1997: Diamandis E P
Clinical applications of tumor suppressor genes and oncogenes in cancer.
Clinica chimica acta; international journal of clinical chemistry 1997;257(2):157-80.
1997: Angelopoulou K; Diamandis E P
Detection of the TP53 tumour suppressor gene product and p53 auto-antibodies in the ascites of women with ovarian cancer.
European journal of cancer (Oxford, England : 1990) 1997;33(1):115-21.
1997: Angelopoulou K; Stratis M; Diamandis E P
Humoral immune response against p53 protein in patients with colorectal carcinoma.
International journal of cancer. Journal international du cancer 1997;70(1):46-51.
1997: Borchert G H; Melegos D N; Tomlinson G; Giai M; Roagna R; Ponzone R; Sgro L; Diamandis E P
Molecular forms of prostate-specific antigen in the serum of women with benign and malignant breast diseases.
British journal of cancer 1997;76(8):1087-94.
1997: Soleas G J; Diamandis E P; Goldberg D M
Wine as a biological fluid: history, production, and role in disease prevention.
Journal of clinical laboratory analysis 1997;11(5):287-313.
1997: Howarth D J; Aronson I B; Diamandis E P
Immunohistochemical localization of prostate-specific antigen in benign and malignant breast tissues.
British journal of cancer 1997;75(11):1646-51.
1997: Zarghami N; Grass L; Diamandis E P
Steroid hormone regulation of prostate-specific antigen gene expression in breast cancer.
British journal of cancer 1997;75(4):579-88.
1996: Melegos D N; Diamandis E P; Oda H; Urade Y; Hayaishi O
Immunofluorometric assay of prostaglandin D synthase in human tissue extracts and fluids.
Clinical chemistry 1996;42(12):1984-91.
1996: Melegos D N; Yu H; Allen L C; Diamandis E P
Prostate-specific antigen in amniotic fluid of normal and abnormal pregnancies.
Clinical biochemistry 1996;29(6):555-62.
1996: Diamandis E P
Prostate specific antigen--new applications in breast and other cancers.
Anticancer research 1996;16(6C):3983-4.
1996: Angelopoulou K; Rosen B; Stratis M; Yu H; Solomou M; Diamandis E P
Circulating antibodies against p53 protein in patients with ovarian carcinoma. Correlation with clinicopathologic features and survival.
Cancer 1996;78(10):2146-52.
1996: Levesque M A; D'Costa M; Diamandis E P
p53 protein is absent from the serum of patients with lung cancer.
British journal of cancer 1996;74(9):1434-40.
1996: Yu H; Levesque M A; Khosravi M J; Papanastasiou-Diamandi A; Clark G M; Diamandis E P
Associations between insulin-like growth factors and their binding proteins and other prognostic indicators in breast cancer.
British journal of cancer 1996;74(8):1242-7.
1996: Melegos D N; Yu H; Diamandis E P
Prostaglandin D2 synthase: a component of human amniotic fluid and its association with fetal abnormalities.
Clinical chemistry 1996;42(7):1042-50.
1996: Melegos D N; Diamandis E P
Diagnostic value of molecular forms of prostate-specific antigen for female breast cancer.
Clinical biochemistry 1996;29(3):193-200.
1996: Diamandis E P; Yu H; Melegos D N
Ultrasensitive prostate-specific antigen assays and their clinical application.
Clinical chemistry 1996;42(6 Pt 1):853-7.
1996: Ferguson R A; Yu H; Kalyvas M; Zammit S; Diamandis E P
Ultrasensitive detection of prostate-specific antigen by a time-resolved immunofluorometric assay and the Immulite immunochemiluminescent third-generation assay: potential applications in prostate and breast cancers.
Clinical chemistry 1996;42(5):675-84.
1996: Goldberg D M; Tsang E; Karumanchiri A; Diamandis E; Soleas G; Ng E
Method to assay the concentrations of phenolic constituents of biological interest in wines.
Analytical chemistry 1996;68(10):1688-94.
1996: Hoffman B R; Yu H; Diamandis E P
Assay of prostate-specific antigen from whole blood spotted on filter paper and application to prostate cancer screening.
Clinical chemistry 1996;42(4):536-44.
1996: Goldberg D M; Garovic-Kocic V; Diamandis E P; Pace-Asciak C R
Wine: does the colour count?
Clinica chimica acta; international journal of clinical chemistry 1996;246(1-2):183-93.
1996: Randell E W; Diamandis E P; Ellis G
Serum prostate-specific antigen measured in children from birth to age 18 years.
Clinical chemistry 1996;42(3):420-3.
1996: Zarghami N; Diamandis E P
Detection of prostate-specific antigen mRNA and protein in breast tumors.
Clinical chemistry 1996;42(3):361-6.
1996: Zarghami N; Giai M; Yu H; Roagna R; Ponzone R; Katsaros D; Sismondi P; Diamandis E P
Creatine kinase BB isoenzyme levels in tumour cytosols and survival of breast cancer patients.
British journal of cancer 1996;73(3):386-90.
1996: Yu H; Diamandis E P; Levesque M; Giai M; Roagna R; Ponzone R; Sismondi P; Monne M; Croce C M
Prostate specific antigen in breast cancer, benign breast disease and normal breast tissue.
Breast cancer research and treatment 1996;40(2):171-8.
1996: Diamandis E P; Yu H; López-Otín C
Prostate specific antigen--a new constituent of breast cyst fluid.
Breast cancer research and treatment 1996;38(3):259-64.
1995: Levesque M A; D'Costa M; Angelopoulou K; Diamandis E P
Time-resolved immunofluorometric assay of p53 protein.
Clinical chemistry 1995;41(12 Pt 1):1720-9.
1995: Galvan B; Christopoulos T K; Diamandis E P
Detection of prostate-specific antigen mRNA by reverse transcription polymerase chain reaction and time-resolved fluorometry.
Clinical chemistry 1995;41(12 Pt 1):1705-9.
1995: Zarghami N; Katsaros D; Yu H; Diamandis E P
Prognostic value of creatine kinase BB isoenzyme in epithelial ovarian carcinoma.
The Canadian journal of oncology 1995;5(3):401-7.
1995: Giai M; Yu H; Roagna R; Ponzone R; Katsaros D; Levesque M A; Diamandis E P
Prostate-specific antigen in serum of women with breast cancer.
British journal of cancer 1995;72(3):728-31.
1995: Levesque M A; Clark G M; Yu H; Diamandis E P
Immunofluorometric analysis of p53 protein and prostate-specific antigen in breast tumours and their association with other prognostic indicators.
British journal of cancer 1995;72(3):720-7.
1995: Diamandis E P
Clinical applications of the p53 tumor suppressor gene.
Clinica chimica acta; international journal of clinical chemistry 1995;237(1-2):79-90.
1995: Zarghami N; Yu H; Diamandis E P; Sutherland D J
Quantification of creatine kinase BB isoenzyme in tumor cytosols and serum with an ultrasensitive time-resolved immunofluorometric technique.
Clinical biochemistry 1995;28(3):243-53.
1995: Yu H; Giai M; Diamandis E P; Katsaros D; Sutherland D J; Levesque M A; Roagna R; Ponzone R; Sismondi P
Prostate-specific antigen is a new favorable prognostic indicator for women with breast cancer.
Cancer research 1995;55(10):2104-10.
1995: Yu H; Diamandis E P; Levesque M; Asa S L; Monne M; Croce C M
Expression of the prostate-specific antigen gene by a primary ovarian carcinoma.
Cancer research 1995;55(8):1603-6.
1995: Levesque M A; Katsaros D; Yu H; Zola P; Sismondi P; Giardina G; Diamandis E P
Mutant p53 protein overexpression is associated with poor outcome in patients with well or moderately differentiated ovarian carcinoma.
Cancer 1995;75(6):1327-38.
1995: Pace-Asciak C R; Hahn S; Diamandis E P; Soleas G; Goldberg D M
The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease.
Clinica chimica acta; international journal of clinical chemistry 1995;235(2):207-19.
1995: Yu H; Diamandis E P; Monne M; Croce C M
Oral contraceptive-induced expression of prostate-specific antigen in the female breast.
The Journal of biological chemistry 1995;270(12):6615-8.
1995: Yu H; Diamandis E P; Prestigiacomo A F; Stamey T A
Ultrasensitive assay of prostate-specific antigen used for early detection of prostate cancer relapse and estimation of tumor-doubling time after radical prostatectomy.
Clinical chemistry 1995;41(3):430-4.
1995: Yu H; Diamandis E P
Measurement of serum prostate specific antigen levels in women and in prostatectomized men with an ultrasensitive immunoassay technique.
The Journal of urology 1995;153(3 Pt 2):1004-8.
1995: Yu H; Diamandis E P
Prostate-specific antigen immunoreactivity in amniotic fluid.
Clinical chemistry 1995;41(2):204-10.
1995: Yu H; Diamandis E P
Prostate-specific antigen in milk of lactating women.
Clinical chemistry 1995;41(1):54-8.
1995: Levesque M; Yu H; D'Costa M; Tadross L; Diamandis E P
Immunoreactive prostate-specific antigen in lung tumors.
Journal of clinical laboratory analysis 1995;9(6):375-9.
1995: Levesque M; Hu H; D'Costa M; Diamandis E P
Prostate-specific antigen expression by various tumors.
Journal of clinical laboratory analysis 1995;9(2):123-8.
1994: Angelopoulou K; Diamandis E P; Sutherland D J; Kellen J A; Bunting P S
Prevalence of serum antibodies against the p53 tumor suppressor gene protein in various cancers.
International journal of cancer. Journal international du cancer 1994;58(4):480-7.
1994: Yu H; Diamandis E P; Sutherland D J
Immunoreactive prostate-specific antigen levels in female and male breast tumors and its association with steroid hormone receptors and patient age.
Clinical biochemistry 1994;27(2):75-9.
1994: Wang T; Diamandis E P; Lane A; Baines A D
Variable selectivity of the Hitachi chemistry analyzer chloride ion-selective electrode toward interfering ions.
Clinical biochemistry 1994;27(1):37-14.
1994: Diamandis E P; Yu H; Sutherland D J
Detection of prostate-specific antigen immunoreactivity in breast tumors.
Breast cancer research and treatment 1994;32(3):301-10.
1994: Yu H; Diamandis E P; Zarghami N; Grass L
Induction of prostate specific antigen production by steroids and tamoxifen in breast cancer cell lines.
Breast cancer research and treatment 1994;32(3):291-300.
1994: Levesque M A; Diamandis E P; Yu H; Sutherland D J
Quantitative analysis of mutant p53 protein in breast tumor cytosols and study of its association with other biochemical prognostic indicators in breast cancer.
Breast cancer research and treatment 1994;30(2):179-95.
1994: Yu H; Diamandis E P; Levesque M; Sismondi P; Zola P; Katsaros D
Ectopic production of prostate specific antigen by a breast tumor metastatic to the ovary.
Journal of clinical laboratory analysis 1994;8(4):251-3.
1993: Goldberg D M; Diamandis E P
Models of neoplasia and their diagnostic implications: a historical perspective.
Clinical chemistry 1993;39(11 Pt 2):2360-74.
1993: Yu H; Diamandis E P
Ultrasensitive time-resolved immunofluorometric assay of prostate-specific antigen in serum and preliminary clinical studies.
Clinical chemistry 1993;39(10):2108-14.
1993: Diamandis E P
Time-resolved fluorometry in nucleic acid hybridization and western blotting techniques.
Electrophoresis 1993;14(9):866-75.
1993: Hassapoglidou S; Diamandis E P; Sutherland D J
Quantification of p53 protein in tumor cell lines, breast tissue extracts and serum with time-resolved immunofluorometry.
Oncogene 1993;8(6):1501-9.
1993: Chan A; Diamandis E P; Krajden M
Quantification of polymerase chain reaction products in agarose gels with a fluorescent europium chelate as label and time-resolved fluorescence spectroscopy.
Analytical chemistry 1993;65(2):158-63.
1993: Diamandis E P; Hassapoglidou S; Bean C C
Evaluation of nonisotopic labeling and detection techniques for nucleic acid hybridization.
Journal of clinical laboratory analysis 1993;7(3):174-9.
1992: Hassapoglidou S; Diamandis E P
Antibodies to the p53 tumor suppressor gene product quantified in cancer patient serum with a time-resolved immunofluorometric technique.
Clinical biochemistry 1992;25(6):445-9.
1992: Diamandis E P; Grass C L; Uldall R; Mendelssohn D; Maini D
An enzymatic method for measuring serum mannitol and its use in hemodialysis patients.
Clinical biochemistry 1992;25(6):457-62.
1992: Papanastasiou-Diamandi A; Christopoulos T K; Diamandis E P
Ultrasensitive thyrotropin immunoassay based on enzymatically amplified time-resolved fluorescence with a terbium chelate.
Clinical chemistry 1992;38(4):545-8.
1992: Kakabakos S E; Christopoulos T K; Diamandis E P
Multianalyte immunoassay based on spatially distinct fluorescent areas quantified by laser-excited solid-phase time-resolved fluorometry.
Clinical chemistry 1992;38(3):338-42.
1992: Diamandis E P; Christopoulos T K; Bean C C
Quantitative western blot analysis and spot immunodetection using time-resolved fluorometry.
Journal of immunological methods 1992;147(2):251-9.
1992: Christopoulos T K; Diamandis E P
Enzymatically amplified time-resolved fluorescence immunoassay with terbium chelates.
Analytical chemistry 1992;64(4):342-6.
1991: Christopoulos T K; Diamandis E P; Wilson G
Quantification of nucleic acids on nitrocellulose membranes with time-resolved fluorometry.
Nucleic acids research 1991;19(21):6015-9.
1991: Diamandis E P
Multiple labeling and time-resolvable fluorophores.
Clinical chemistry 1991;37(9):1486-91.
1991: Diamandis E P; Christopoulos T K
The biotin-(strept)avidin system: principles and applications in biotechnology.
Clinical chemistry 1991;37(5):625-36.
1990: Diamandis E P
Analytical methodology for immunoassays and DNA hybridization assays--current status and selected systems--critical review.
Clinica chimica acta; international journal of clinical chemistry 1990;194(1):19-50.
1990: Diamandis E P; Christopoulos T K
Europium chelate labels in time-resolved fluorescence immunoassays and DNA hybridization assays.
Analytical chemistry 1990;62(22):1149A-1157A.
1990: Diamandis E P
Detection techniques for immunoassay and DNA probing applications.
Clinical biochemistry 1990;23(5):437-43.
1990: Lianidou E S; Christopoulos T K; Diamandis E P
Assay of creatine kinase isoenzyme MB in serum with time-resolved immunofluorometry.
Clinical chemistry 1990;36(9):1679-83.
1990: Christopoulos T K; Lianidou E S; Diamandis E P
Ultrasensitive time-resolved fluorescence method for alpha-fetoprotein.
Clinical chemistry 1990;36(8 Pt 1):1497-502.
1990: Diamandis E P; Ogilvie R R
Ultrasensitive time-resolved immunofluorometry of human albumin in urine using monoclonal antibodies--a new assay for microalbuminuria.
Annals of clinical biochemistry 1990;27 ( Pt 3)():232-7.
1990: Kahan I; Papanastasiou-Diamandi A; Ellis G; Makela S K; McLaurin J; D'Costa M; Diamandis E P
Sensitive time-resolved fluorescence immunoassay of somatotropin in serum.
Clinical chemistry 1990;36(3):503-8.
1990: Shankaran P; Reichstein E; Khosravi M J; Diamandis E P
Detection of immunoglobulins G and M to rubella virus by time-resolved immunofluorometry.
Journal of clinical microbiology 1990;28(3):573-9.
1990: Christopoulos T K; Diamandis E P
Binding studies using ion-selective electrodes. Examination of the picrate-albumin interaction as a model system.
Analytical chemistry 1990;62(4):360-7.
1989: Bhayana V; Diamandis E P
A double monoclonal time-resolved immunofluorometric assay of carcinoembryonic antigen in serum.
Clinical biochemistry 1989;22(6):433-8.
1989: Diamandis E P; Papanastasiou-Diamandi A; Lustig V; Khosravi M J; Tan A
Time-resolved immunofluorometric assay of human pancreatic isoamylase in serum, with use of two monoclonal antibodies.
Clinical chemistry 1989;35(9):1915-20.
1989: Papanastasiou-Diamandi A; Conway K; Diamandis E P
Digoxin immunoassay with monoclonal and polyclonal antibodies using time-resolved fluorometry.
Journal of pharmaceutical sciences 1989;78(8):617-21.
1989: Papanastasiou-Diamandis A; Bhayana V; Diamandis E P
A simple time-resolved fluoroimmunoassay of total thyroxine in serum.
Annals of clinical biochemistry 1989;26 ( Pt 3)():238-43.
1989: Diamandis E P
Time-resolved fluorescence immunoassay system especially suited for research applications.
Clinical chemistry 1989;35(3):491.
1989: Reichstein E; Morton R C; Diamandis E P
Sensitive time-resolved immunofluorometric assay of thyrotropin in serum.
Clinical biochemistry 1989;22(1):23-9.
1989: Diamandis E P; Morton R C; Reichstein E; Khosravi M J
Multiple fluorescence labeling with europium chelators. Application to time-resolved fluoroimmunoassays.
Analytical chemistry 1989;61(1):48-53.
1989: Khosravi M J; Diamandis E P
Time-resolved immunofluorometry of follitropin in serum.
Clinical chemistry 1989;35(1):181.
1989: Tan Y K; Khosravi M J; Diamandis E P
Time-resolved immunofluorometric assay for thyroxine-binding globulin in serum.
Journal of immunoassay 1989;10(4):413-28.
1988: Diamandis E P; Bhayana V; Conway K; Reichstein E; Papanastasiou-Diamandis A
Time-resolved fluoroimmunoassay of cortisol in serum with a europium chelate as label.
Clinical biochemistry 1988;21(5):291-6.
1988: Khosravi M J; Morton R C; Diamandis E P
Sensitive, rapid procedure for time-resolved immunofluorometry of lutropin.
Clinical chemistry 1988;34(8):1640-4.
1988: Khosravi M J; Chan M A; Bellem A C; Diamandis E P
A sensitive time-resolved immunofluorometric assay of ferritin in serum with monoclonal antibodies.
Clinica chimica acta; international journal of clinical chemistry 1988;175(3):267-75.
1988: Evangelista R A; Pollak A; Allore B; Templeton E F; Morton R C; Diamandis E P
A new europium chelate for protein labelling and time-resolved fluorometric applications.
Clinical biochemistry 1988;21(3):173-8.
1988: Diamandis E P
Immunoassays with time-resolved fluorescence spectroscopy: principles and applications.
Clinical biochemistry 1988;21(3):139-50.
1988: Diamandis E P; D'Costa M
Selective determination of urinary free cortisol by liquid chromatography after solid-state extraction.
Journal of chromatography 1988;426(1):25-32.
1987: Yannakou L; Diamandis E P; Souvatzoglou A
Effect of incubation time and temperature on the interference of digoxin-like immunoreactive substances in digoxin immunoassays.
Therapeutic drug monitoring 1987;9(4):461-3.
1987: Khosravi M J; Diamandis E P
Immunofluorometry of choriogonadotropin by time-resolved fluorescence spectroscopy, with a new europium chelate as label.
Clinical chemistry 1987;33(11):1994-9.
1987: Chan M A; Bellem A C; Diamandis E P
Time-resolved immunofluorometric assay of alpha-fetoprotein in serum and amniotic fluid, with a novel detection system.
Clinical chemistry 1987;33(11):2000-3.
1987: Mitsana-Papazoglou A; Christopoulos T K; Diamandis E P; Koupparis M A
Dissolution studies of drug formulations using ion-selective electrodes as sensors in an air-segmented continuous flow analyzer.
Journal of pharmaceutical sciences 1987;76(9):724-30.
1987: Mitsana-Papazoglou A; Diamandis E P; Hadjiioannou T P
Ion-selective electrodes for the H2-receptor antagonists cimetidine and ranitidine.
Journal of pharmaceutical sciences 1987;76(6):485-91.
1985: Mitsana-Papazoglou A; Christopoulos T K; Diamandis E P; Hadjiioannou T P
Construction of ion-selective electrodes for chlorpromazine, amitriptyline, propantheline and meperidine: analytical study and application to pharmaceutical analysis.
The Analyst 1985;110(9):1091-4.
1983: Siskos P A; Diamandis E P; Gillieron E; Colbert J C
Potentiometric titration of sulphate, sulphite and dithionate mixtures, with use of a lead ion-selective electrode.
Talanta 1983;30(12):980-2.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Eleftherios Diamandis

Research Profile (preview)

Chemicals & Drugs

Disorders

Procedures

Concepts & Ideas

Physiology

Genes & Molecular Sequences

Anatomy

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Eleftherios Diamandis (preview)

All Publications